10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended December 29, 2018

Commission File Number 001-35672

BERRY GLOBAL GROUP, INC.

 A Delaware corporation  101 Oakley Street, Evansville, Indiana, 47710 (812) 424-2904  IRS employer identification number 20-5234618

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (the "Exchange Act"):

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  Yes  ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒ No ☐  

Indicate by check mark whether the registrant is a large accelerated filer, accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒        Accelerated filer  ☐     Non-accelerated filer ☐  Smaller reporting company  ☐      Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 12b-2 of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.

Yes  ☐     No  ☒

Class	Outstanding at February 1, 2019
Common Stock, $.01 par value per share	130.3 million shares

1

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

This Form 10-Q includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to our financial condition, results of operations and business and our expectations or beliefs concerning future events.  The forward-looking statements include, in particular, statements about our plans, strategies and prospects under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations."  These statements contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “outlook,” “anticipates” or “looking forward” or similar expressions that relate to our strategy, plans, intentions, or expectations.  All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates and financial results or to our expectations regarding future industry trends are forward-looking statements.  In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments.  These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected.  We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions.  While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results.  All forward-looking statements are based upon information available to us on the date of this Form 10-Q. 

Readers should carefully review the factors discussed in our most recent Form 10-K in the section titled "Risk Factors" and other risk factors identified from time to time in our periodic filings with the Securities and Exchange Commission.

2

Berry Global Group, Inc.

Form 10-Q Index

For Quarterly Period Ended December 29, 2018

Part I.	Financial Information		Page No.
	Item 1.	Financial Statements:
		Consolidated Statements of Income and Comprehensive Income	4
		Consolidated Balance Sheets	5
		Consolidated Statements of Changes in Stockholders' Equity	6
		Consolidated Statements of Cash Flows	7
		Notes to Consolidated Financial Statements	8
	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	19
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	23
	Item 4.	Controls and Procedures	24
Part II.	Other Information
	Item 1.	Legal Proceedings	25
	Item 1A.	Risk Factors	25
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	26
	Item 6.	Exhibits	27
	Signature		28

3

Part I. Financial Information

Item 1. Financial Statements

Berry Global Group, Inc.

Consolidated Statements of Income

(Unaudited)

(in millions of dollars, except per share amounts)

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales	$	1,972	$	1,776
Costs and expenses:
Cost of goods sold		1,619		1,447
Selling, general and administrative		124		117
Amortization of intangibles		42		38
Restructuring and impairment charges		11		11
Operating income		176		163
Other (income) expense, net		—		9
Interest expense, net		64		62
Income before income taxes		112		92
Income tax expense (benefit)		24		(71	)
Net income	$	88	$	163
Net income per share:
Basic	$	0.67	$	1.24
Diluted		0.66		1.20
Outstanding weighted-average shares:
Basic		131.1		131.0
Diluted		133.8		136.0

Consolidated Statements of Comprehensive Income

(Unaudited)

(in millions of dollars) 

	Quarterly Period Ended
	December 29, 2018			December 30, 2017
Net income	$	88		$	163
Currency translation		(4	)		(24	)
Pension and other postretirement benefits		—			(1	)
Interest rate hedges		(24	)		17
Provision for income taxes		7			(4	)
Other comprehensive loss, net of tax		(21	)		(12	)
Comprehensive income	$	67		$	151

See notes to consolidated financial statements.

4

Berry Global Group, Inc.

Consolidated Balance Sheets

(in millions of dollars)

	December 29, 2018			September 29, 2018
Assets	(Unaudited)
Current assets:
Cash and cash equivalents	$	293		$	381
Accounts receivable (less allowance of $13)		879			941
Inventories:
Finished goods		545			503
Raw materials and supplies		411			384
		956			887
Prepaid expenses and other current assets		78			76
Total current assets		2,206			2,285
Property, plant, and equipment, net		2,457			2,488
Goodwill and intangible assets, net		4,243			4,284
Other assets		66			74
Total assets	$	8,972		$	9,131
Liabilities
Current liabilities:
Accounts payable	$	715		$	783
Accrued expenses and other current liabilities		427			416
Current portion of long-term debt		37			38
Total current liabilities		1,179			1,237
Long-term debt, less current portion		5,700			5,806
Deferred income taxes		357			365
Other long-term liabilities		281			289
Total liabilities		7,517			7,697
Stockholders' equity
Common stock (130.6 and 131.4 million shares issued, respectively)		1			1
Additional paid-in capital		873			867
Non-controlling interest		3			3
Retained earnings		755			719
Accumulated other comprehensive loss		(177	)		(156	)
Total stockholders' equity		1,455			1,434
Total liabilities and stockholders' equity	$	8,972		$	9,131

See notes to consolidated financial statements.

5

Berry Global Group, Inc.

Consolidated Statements of Changes in Stockholders' Equity

(Unaudited)

(in millions of dollars)

	Common Stock		Additional Paid-in Capital			Non-Controlling Interest		Accumulated Other Comprehensive Loss			Retained Earnings			Total
Balance at September 30, 2017	$	1	$	823		$	3	$	(68	)	$	256		$	1,015
Share-based compensation expense		—		4			—		—			—			4
Proceeds from issuance of common stock		—		4			—		—			—			4
Interest rate hedges, net of tax		—		—			—		13			—			13
Net income attributable to the Company		—		—			—		—			163			163
Currency translation		—		—			—		(24	)		—			(24	)
Pension		—		—			—		(1	)		—			(1	)
Balance at December 30, 2017	$	1	$	831		$	3	$	(80	)	$	419		$	1,174
Balance at September 29, 2018	$	1	$	867		$	3	$	(156	)	$	719		$	1,434
Share-based compensation expense		—		3			—		—			—			3
Proceeds from issuance of common stock		—		5			—		—			—			5
Common stock repurchased and retired		—		(2	)		—		—			(52	)		(54	)
Interest rate hedges, net of tax		—		—			—		(17	)		—			(17	)
Net income attributable to the Company		—		—			—		—			88			88
Currency translation		—		—			—		(4	)		—			(4	)
Balance at December 29, 2018	$	1	$	873		$	3	$	(177	)	$	755		$	1,455

See notes to consolidated financial statements.

6

Berry Global Group, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

(in millions of dollars)

	Quarterly Period Ended
	December 29, 2018			December 30, 2017
Cash Flows from Operating Activities:
Net income	$	88		$	163
Adjustments to reconcile net cash provided by operating activities:
Depreciation		96			91
Amortization of intangibles		42			38
Non-cash interest expense		(1	)		3
Deferred income tax		4			(121	)
Share-based compensation expense		3			4
Other non-cash operating activities, net		4			6
Changes in working capital		(71	)		(66	)
Changes in other assets and liabilities		(4	)		35
Net cash from operating activities		161			153
Cash Flows from Investing Activities:
Additions to property, plant and equipment		(75	)		(94	)
Proceeds from sale of assets		—			3
Net cash from investing activities		(75	)		(91	)
Cash Flows from Financing Activities:
Repayments on long-term borrowings		(110	)		(108	)
Proceeds from issuance of common stock		5			4
Repurchase of common stock		(52	)		—
Payment of tax receivable agreement		(16	)		(37	)
Net cash from financing activities		(173	)		(141	)
Effect of exchange rate changes on cash		(1	)		1
Net change in cash		(88	)		(78	)
Cash and cash equivalents at beginning of period		381			306
Cash and cash equivalents at end of period	$	293		$	228

See notes to consolidated financial statements.

7

Berry Global Group, Inc.

Notes to Consolidated Financial Statements

(Unaudited)

(tables in millions of dollars, except per share data)

1.  Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.  In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period.  Actual results could differ from those estimates.  Certain reclassifications have been made to prior periods to conform to current reporting.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated.  For further information, refer to the Company's most recent Form 10-K filed with the Securities and Exchange Commission.

2.  Recently Issued Accounting Pronouncements

Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification.  During fiscal 2019, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2018 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements.

Revenue Recognition

In May 2014, the FASB issued a final standard on revenue recognition.  Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein.  An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings.  The Company adopted the new standard effective for fiscal 2019 using the modified retrospective approach.  The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

Leases

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements.  Under the new standard, the lessee of an operating lease will be required to do the following: 1) recognize a right-of-use asset and a lease liability in the statement of financial position, 2) recognize a single lease cost allocated over the lease term generally on a straight-line basis, and 3) classify all cash payments within operating activities on the statement of cash flows.  Companies are required to adopt this standard using a modified retrospective transition method.  Amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years.  The Company is currently evaluating the impact of this standard, which will be effective for the Company beginning fiscal 2020.

3.  Revenue Recognition

Our revenues are primarily derived from the sale of plastic packaging products to customers.  Revenue is recognized when performance obligations are satisfied, in an amount reflecting the consideration the Company expects to be entitled.  We consider the promise to transfer products to be our sole performance obligation.  If the consideration agreed to in a contract includes a variable amount, we estimate the amount of consideration we expect to be entitled to in exchange for transferring the promised goods to the customer using the most likely amount method.  Our main sources of variable consideration are customer rebates and cash discounts.  There are no material instances where variable consideration is constrained and not recorded at the initial time of sale.  Generally our revenue is recognized at a point in time for standard promised goods at the time of shipment, when title and risk of loss pass to the customer.  A small number of our contracts are for sales of products which are customer specific and cannot be repurposed. Sales for these products qualify for over time recognition and are immaterial to the Company.

8

Our rebate programs are individually negotiated with customers and contain a variety of different terms and conditions.  Certain rebates are calculated as flat percentages of purchases, while others included tiered volume incentives.  These rebates may be payable monthly, quarterly, or annually.  The calculation of the accrued rebate balance involves management estimates, especially where the terms of the rebate involve tiered volume levels that require estimates of expected annual sales.  These provisions are based on estimates derived from current program requirements and historical experience.  The accrual for customer rebates was $64 million and $58 million at December 29, 2018 and September 29, 2018, respectively, and is included in Accrued expenses and other current liabilities.

Due to the nature of our sales transactions, we have elected the following practical expedients: (i) Shipping and handling costs are treated as fulfillment costs. Accordingly, shipping and handling costs are classified as a component of Cost of goods sold while amounts billed to customers are classified as a component of Net Sales; (ii) We exclude sales and similar taxes that are imposed on our sales and collected from customers; (iii) As our standard payment terms are less than one year, we did not assess whether a contract has a significant financing component.

The Company disaggregates revenue based on reportable business segment, geography, and significant product line.  Refer to Note 11. Operating Segments for further information.

4.  Acquisitions

Laddawn, Inc.

In August 2018, the Company acquired Laddawn, Inc. ("Laddawn") for a purchase price of $242 million, which is preliminary and subject to adjustment.  Laddawn is a custom bag and film manufacturer with a unique-to-industry e-commerce sales platform.  The acquired business is operated in our Engineered Materials segment.  To finance the purchase, the Company used existing liquidity.

The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary estimates of fair value at the acquisition date.  The results of Laddawn have been included in the consolidated results of the Company since the date of the acquisition.  The Company has not finalized the allocation of the purchase price to the fair value of the assets acquired and liabilities assumed.  The assets acquired and liabilities assumed consisted of working capital of $26 million, property and equipment of $39 million, intangible assets of $98 million, and goodwill of $79 million.  The working capital includes a $2 million step up of inventory to fair value.  The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes.

Clopay Plastic Products Company, Inc.

In February 2018, the Company acquired Clopay Plastic Products Company, Inc. ("Clopay") for a purchase price of $475 million.  Clopay is an innovator in the development of printed breathable films, elastic films, and laminates with product offerings uniquely designed for applications used in a number of markets including: hygiene, healthcare, construction and industrial protective apparel.  The acquired business is operated within our Health, Hygiene & Specialties segment.  To finance the purchase, the Company issued $500 million aggregate principal amount of 4.5% second priority notes through a private placement offering.

The acquisition has been accounted for under the purchase method of accounting, and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on fair values at the acquisition date.  The results of Clopay have been included in the consolidated results of the Company since the date of the acquisition.  The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes.  The following table summarizes the purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5

(a) Includes a $3 million step up of inventory to fair value

9

5.  Accounts Receivable Factoring Agreements

The Company has entered into various factoring agreements, both in the U.S. and at a number of foreign subsidiaries, to sell certain receivables to unrelated third-party financial institutions. The Company accounts for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860").  ASC 860 allows for the ownership transfer of accounts receivable to qualify for sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheets.  Receivables are considered sold when (i) they are transferred beyond the reach of the Company and its creditors, (ii) the purchaser has the right to pledge or exchange the receivables, and (iii) the Company has surrendered control over the transferred receivables.  In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold.

There were no amounts outstanding from financial institutions related to U.S. based programs at December 29, 2018 or September 29, 2018.  Gross amounts factored under these U.S. based programs at December 29, 2018 and September 29, 2018 were $212 million and $162 million, respectively.  The fees associated with transfer of receivables for all programs were not material for any of the periods presented.

6.  Restructuring and Impairment Charges

The Company incurred restructuring costs of $11 million for both the quarterly period ended December 29, 2018 and December 30, 2017, respectively.  The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Consumer Packaging	$	—	$	1
Health, Hygiene & Specialties		10		10
Engineered Materials		1		—
Consolidated	$	11	$	11

The table below sets forth the activity with respect to the restructuring accrual at December 29, 2018:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance at September 29, 2018	$	9			4			—		$	13
Charges		3			1			7			11
Non-cash asset impairment		—			—			(7	)		(7	)
Cash payments		(6	)		(1	)		—			(7	)
Balance at December 29, 2018	$	6			4			—		$	10

7.  Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Employee compensation	$	106	$	113
Accrued taxes		79		72
Rebates		64		58
Interest		43		49
Tax receivable agreement obligation		12		16
Restructuring		10		13
Accrued operating expenses		113		95
	$	427	$	416

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Uncertain tax positions	$	68	$	67
Deferred purchase price		43		40
Pension liability		42		45
Lease retirement obligation		40		39
Sale-lease back deferred gain		21		21
Transition tax		18		18
Derivative instruments		13		12
Tax receivable agreement obligation		12		23
Other		24		24
	$	281	$	289

10

8.  Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	December 29, 2018			September 29, 2018
Term loan	February 2020	$	700		$	800
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,545
Term loan	January 2024		493			493
Revolving line of credit	May 2020		—			—
5 1/2% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 1/8% Second Priority Senior Secured Notes	July 2023		700			700
4 1/2% Second Priority Senior Secured Notes	February 2026		500			500
Debt discounts and deferred fees			(40	)		(43	)
Capital leases and other	Various		125			135
Total long-term debt			5,737			5,844
Current portion of long-term debt			(37	)		(38	)
Long-term debt, less current portion		$	5,700		$	5,806

The Company was in compliance with all debt covenants for all periods presented.

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense through maturity.

Term Loans

The term loans with a maturity date of February 2020 and January 2021 bear interest at LIBOR plus 1.75%.  The term loans with a maturity date of October 2022 and January 2024 bear interest at LIBOR plus 2.00%.

During fiscal 2019, the Company has made $110 million of repayments on long-term borrowings using existing liquidity.

9.  Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors.  The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies.  These financial instruments are not used for trading or other speculative purposes.  For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

To the extent hedging relationships are found to be effective, as determined by FASB guidance, changes in the fair value of the derivatives are offset by changes in the fair value of the related hedged item and recorded to Accumulated other comprehensive loss. Any identified ineffectiveness, or changes in the fair value of a derivative not designated as a hedge, is recorded to the Consolidated Statements of Income.

Cross-Currency Swaps

The Company is party to certain cross-currency swap agreements with a notional amount of 250 million euro to effectively convert a portion of our fixed-rate U.S. dollar denominated term loans, including the monthly interest payments, to fixed-rate euro-denominated debt.  The swap agreements mature in May 2022.  The risk management objective is to manage foreign currency risk relating to net investments in certain European subsidiaries denominated in foreign currencies and reduce the variability in the functional currency cash flows of a portion of the Company’s term loans.  Changes in fair value of the derivative instruments are recognized in a component of Accumulated other comprehensive loss, to offset the changes in the values of the net investments being hedged.

11

Interest Rate Swaps

The primary purpose of the Company’s interest rate swap activities is to manage cash flow variability associated with our outstanding variable rate term loan debt.

During fiscal 2017 the Company modified various term loan rates and maturities.  In conjunction with these modifications the Company realigned existing swap agreements which resulted in the de-designation of the original hedge and re-designation of the modified swaps as effective cash flow hedges.  The amounts included in Accumulated other comprehensive loss at the date of de-designation are being amortized to Interest expense through the terms of the original swaps.

As of December 29, 2018, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.000%, with an effective date in May 2017 and expiration in May 2022 and (ii) a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date in June 2018 and expiration in September 2021.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized.  Balances on a gross basis are as follows:

Derivatives Instruments	Hedge Designation	Balance Sheet Location	December 29, 2018		September 29, 2018
Cross-currency swaps	Designated	Other long-term liabilities	$	3	$	11
Interest rate swaps	Designated	Other assets		7		16
Interest rate swaps	Designated	Other long-term liabilities		10		—
Interest rate swaps	Not designated	Other long-term liabilities		—		1

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended
Derivatives instruments	Statement of Operations Location	December 29, 2018				December 30, 2017
Foreign currency swaps	Other (income) expense, net		$	(4	)		$	2
Interest rate swaps	Interest expense, net			(2	)			(1	)

The amortization related to unrealized losses in Accumulated other comprehensive loss is expected to be $9 million in the next 12 months.

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition.  The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values.  The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value.  These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment.  The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist.  The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2018 assessment.  No impairment indicators were identified in the current quarter.

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of December 29, 2018 and September 29, 2018, along with the impairment loss recognized on the fair value measurement during the period:

	As of December 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,941		2,941		—
Definite lived intangible assets		—		—		1,054		1,054		—
Property, plant, and equipment		—		—		2,457		2,457		7
Total	$	—	$	—	$	6,700	$	6,700	$	7

12

	As of September 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant, and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	—

The Company's financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, and capital lease obligations.  The book value of our long-term indebtedness exceeded fair value by $45 million as of December 29, 2018.  The Company's long-term debt fair values were determined using Level 2 inputs as other significant observable inputs were not available.  

10.  Income Taxes

In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”).  The transitional impacts of the Tax Act resulted in a transition benefit of $95 million in the quarterly period ended December 30, 2017.  During the Quarter, the Company completed the accounting for the Tax Act, resulting in an immaterial change from fiscal 2018.

The effective tax rate was 21% for the quarterly period ended December 29, 2018 and was positively impacted by 2% from the share-based compensation excess tax benefit deduction, 1% from research and development credits, and other discrete items.  These favorable items were offset by increases of 4% from U.S. state income taxes and other discrete items.

11.  Operating Segments

The Company's operations are organized into three operating segments: Engineered Materials, Health, Hygiene & Specialties, and Consumer Packaging.  The structure is designed to align us with our customers, provide optimal service, and drive future growth in a cost efficient manner.  Selected information by reportable segment is presented in the following tables: 

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales:
Engineered Materials	$	669	$	648
Health, Hygiene & Specialties		702		577
Consumer Packaging		601		551
Total net sales	$	1,972	$	1,776
Operating income:
Engineered Materials	$	94	$	88
Health, Hygiene & Specialties		49		37
Consumer Packaging		33		38
Total operating income	$	176	$	163
Depreciation and amortization:
Engineered Materials	$	31	$	29
Health, Hygiene & Specialties		54		46
Consumer Packaging		53		54
Total depreciation and amortization	$	138	$	129

	December 29, 2018		September 29, 2018
Total assets:
Engineered Materials	$	1,964	$	1,998
Health, Hygiene & Specialties		3,811		3,913
Consumer Packaging		3,197		3,220
Total assets	$	8,972	$	9,131
Total goodwill:
Engineered Materials	$	630	$	633
Health, Hygiene & Specialties		903		902
Consumer Packaging		1,408		1,409
Total goodwill	$	2,941	$	2,944

13

Selected information by geography is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018			December 30, 2017
Net sales:
North America		$	1,605		$	1,466
South America			96			74
Europe			204			170
Asia			67			66
Total net sales		$	1,972		$	1,776
	December 29, 2018			September 29, 2018
Long-lived assets:
North America		$	5,685		$	5,764
South America			332			320
Europe			451			463
Asia			298			299
Total long-lived assets:		$	6,766		$	6,846

Selected information by product line is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018			December 30, 2017
Net sales:
Performance Materials		39			43
Engineered Products		61			57
Engineered Materials		100	%		100	%
Health		18			19
Hygiene		52			44
Specialties		30			37
Health, Hygiene & Specialties		100	%		100	%
Rigid Open Top		44			43
Rigid Closed Top		56			57
Consumer Packaging		100	%		100	%

12.  Contingencies and Commitments

The Company is party to various legal proceedings involving routine claims which are incidental to its business.  Although the Company's legal and financial liability with respect to such proceedings cannot be estimated with certainty, management believes that any ultimate liability would not be material to its financial statements.

The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

14

13.  Share Repurchase Program

In fiscal 2018, the Company announced a $500 million share repurchase program.  Berry may repurchase shares through the open market, privately negotiated transactions, or other programs, subject to market conditions.  This authorization has no expiration date and may be suspended at any time.

During the quarterly period ended December 29, 2018, the Company repurchased approximately 1,132 thousand shares for $54 million.  As of December 29, 2018, $412 million of authorized share repurchases remain available to the Company.

14.  Basic and Diluted Net Income Per Share

Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents.  Diluted net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method.  For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive.  For the three months ended December 29, 2018, 3 million shares were excluded from the diluted net income per share calculation as their effect would be anti-dilutive.

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations:

	Quarterly Period Ended
(in millions, except per share amounts)	December 29, 2018		December 30, 2017
Numerator
Consolidated net income	$	88	$	163
Denominator
Weighted average common shares outstanding - basic		131.1		131.0
Dilutive shares		2.7		5.0
Weighted average common and common equivalent shares outstanding - diluted		133.8		136.0
Per common share income
Basic	$	0.67	$	1.24
Diluted	$	0.66	$	1.20

15.  Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows: 

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 29, 2018	$	(175	)	$	(13	)	$	32		$	(156	)
Other comprehensive income (loss) before reclassifications		(4	)		—			(22	)		(26	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(2	)		(2	)
Provision for income taxes		—			—			7			7
Balance at December 29, 2018	$	(179	)	$	(13	)	$	15		$	(177	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 30, 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss) before reclassifications		(24	)		(1	)		14			(11	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			3			3
Provision for income taxes		—			—			(4	)		(4	)
Balance at December 30, 2017	$	(72	)	$	(17	)	$	9		$	(80	)

15

16.  Guarantor and Non-Guarantor Financial Information 

Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this Note, “Parent”) and substantially all of Issuer’s domestic subsidiaries.  Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis.  A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances:  the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other indebtedness of the issuer.  The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company’s debts.  Parent also guarantees the Issuer’s term loans and revolving credit facilities.  The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility.  Presented below is condensed consolidating financial information for the Parent, Issuer, guarantor subsidiaries and non-guarantor subsidiaries.  The Issuer and guarantor financial information includes all of our domestic operating subsidiaries; our non-guarantor subsidiaries include our foreign subsidiaries, certain immaterial domestic subsidiaries and the unrestricted subsidiaries under the Issuer’s indentures.  The Parent uses the equity method to account for its ownership in the Issuer in the Condensed Consolidating Supplemental Financial Statements.  The Issuer uses the equity method to account for its ownership in the guarantor and non-guarantor subsidiaries.  All consolidating entries are included in the eliminations column along with the elimination of intercompany balances.

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	141		$	1,377	$	454		$	—		$	1,972
Cost of goods sold		—			85			1,142		392			—			1,619
Selling, general and administrative		—			13			87		24			—			124
Amortization of intangibles		—			—			36		6			—			42
Restructuring and impairment charges		—			—			7		4			—			11
Operating income		—			43			105		28			—			176
Other expense (income), net		—			1			1		(2	)		—			—
Interest expense, net		—			5			45		14			—			64
Equity in net income of subsidiaries		(112	)		(67	)		—		—			179			—
Income before income taxes		112			104			59		16			(179	)		112
Income tax expense		24			16			—		8			(24	)		24
Net income	$	88		$	88		$	59	$	8		$	(155	)	$	88
Comprehensive net income	$	88		$	79		$	59	$	(4	)	$	(155	)	$	67

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	138		$	1,225	$	413		$	—		$	1,776
Cost of goods sold		—			106			989		352			—			1,447
Selling, general and administrative		—			12			80		25			—			117
Amortization of intangibles		—			—			31		7			—			38
Restructuring and impairment charges		—			—			7		4			—			11
Operating income (loss)		—			20			118		25			—			163
Other income, net		—			5			7		(3	)		—			9
Interest expense, net		—			5			43		14			—			62
Equity in net income of subsidiaries		(92	)		(72	)		—		—			164			—
Income before income taxes		92			82			68		14			(164	)		92
Income tax expense		(71	)		(81	)		—		10			71			(71	)
Net income	$	163		$	163		$	68	$	4		$	(235	)	$	163
Comprehensive net income	$	163		$	160		$	68	$	(5	)	$	(235	)	$	151

16

Condensed Supplemental Consolidated Balance Sheets

	December 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		214		1,243		749		—			2,206
Intercompany receivable		248		1,878		—		28		(2,154	)		—
Property, plant, and equipment, net		—		79		1,660		718		—			2,457
Other assets		1,593		6,326		4,808		486		(8,904	)		4,309
Total assets	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972
Current liabilities		18		248		621		292		—			1,179
Intercompany payable		—		—		2,154		—		(2,154	)		—
Other long-term liabilities		368		5,851		58		61		—			6,338
Stockholders' equity		1,455		2,398		4,878		1,628		(8,904	)		1,455
Total liabilities and stockholders' equity	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972

	September 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		249		1,240		796		—			2,285
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Other assets		1,544		6,247		4,849		487		(8,769	)		4,358
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131
Current liabilities		18		218		635		366		—			1,237
Intercompany payable		—		—		2,252		—		(2,252	)		—
Other long-term liabilities		388		5,945		68		59		—			6,460
Stockholders' equity		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and stockholders' equity	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Statements of Cash Flows

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	55		$	155		$	(49	)	$	—		$	161
Cash Flow from Investing Activities
Additions to  property, plant, and equipment		—			—			(59	)		(16	)		—			(75	)
Proceeds from sale of assets		—			—			—			—			—			—
(Contributions) distributions to/from subsidiaries		47			(47	)		—			—			—			—
Intercompany advances (repayments)		—			38			—			—			(38	)		—
Net cash from investing activities		47			(9	)		(59	)		(16	)		(38	)		(75	)
Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(108	)		(2	)		—			—			(110	)
Proceeds from issuance of common stock		5			—			—			—			—			5
Repurchase of common stock		(52	)		—			—			—			—			(52	)
Payment of tax receivable agreement		(16	)		—			—			—			—			(16	)
Changes in intercompany balances		16			—			(93	)		39			38			—
Net cash from financing activities		(47	)		(108	)		(95	)		39			38			(173	)
Effect of exchange rate changes on cash		—			—			—			(1	)		—			(1	)
Net change in cash		—			(62	)		1			(27	)		—			(88	)
Cash and cash equivalents at beginning of period		—			133			4			244			—			381
Cash and cash equivalents at end of period	$	—		$	71		$	5		$	217		$	—		$	293

17

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	35		$	139		$	(21	)	$	—		$	153
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(3	)		(61	)		(30	)		—			(94	)
Proceeds from sale of assets		—			—			—			3			—			3
(Contributions) distributions to/from subsidiaries		(4	)		4			—			—			—			—
Intercompany advances (repayments)		—			69			—			—			(69	)		—
Other investing activities, net		—			—			—			—			—			—
Net cash from investing activities		(4	)		70			(61	)		(27	)		(69	)		(91	)
Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(106	)		(2	)		—			—			(108	)
Proceeds from issuance of common stock		4			—			—			—			—			4
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Changes in intercompany balances		37			—			(86	)		(20	)		69			—
Net cash from financing activities		4			(106	)		(88	)		(20	)		69			(141	)
Effect of exchange rate changes on cash		—			—			—			1			—			1
Net change in cash		—			(1	)		(10	)		(67	)		—			(78	)
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	17		$	2		$	209		$	—		$	228

18

Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations

This discussion contains forward-looking statements and involves numerous risks and uncertainties, including, but not limited to, those described in our most recent Form 10-K in the section titled "Risk Factors" and other risk factors identified from time to time in our periodic filings with the Securities and Exchange Commission.  As a result, our actual results may differ materially from those contained in any forward-looking statements.  The forward-looking statements referenced within this report should be read with the explanation of the qualifications and limitations included herein.  Fiscal 2018 and fiscal 2019 are fifty-two week periods.

Executive Summary

Business.  The Company's operations are organized into three operating segments: Engineered Materials, Health, Hygiene & Specialties, and Consumer Packaging.  The structure is designed to align us with our customers, provide optimal service, and drive future growth in a cost efficient manner.  The Engineered Materials segment primarily consists of tapes and adhesives, polyethylene based film products, can liners, printed films, and specialty coated, and laminated products.  The Health, Hygiene & Specialties segment primarily consists of nonwoven specialty materials and films used in hygiene, infection prevention, personal care, industrial, construction and filtration applications.  The Consumer Packaging segment primarily consists of containers, foodservice items, closures, overcaps, bottles, prescription containers, and tubes.

Acquisitions.  Our acquisition strategy is focused on improving our long-term financial performance, enhancing our market positions, and expanding our existing and complementary product lines. We seek to obtain businesses for attractive post-synergy multiples, creating value for our stockholders from synergy realization, leveraging the acquired products across our customer base, creating new platforms for future growth, and assuming best practices from the businesses we acquire.  While the expected benefits on earnings is estimated at the commencement of each transaction, once the execution of the plan and integration occur, we are generally unable to accurately estimate or track what the ultimate effects have been due to system integrations and movements of activities to multiple facilities. As historical business combinations and restructuring plans have not allowed us to accurately separate realized synergies compared to what was initially identified, we measure the synergy realization based on the overall segment profitability post integration.

Laddawn, Inc.

In August 2018, the Company acquired Laddawn, Inc. ("Laddawn") for a purchase price of $242 million, which is preliminary and subject to adjustment.  Laddawn is a custom bag and film manufacturer with a unique-to-industry e-commerce sales platform.  Laddawn reported $145 million in net sales for the twelve months ended July 31, 2018, and is operated in our Engineered Materials segment.  The Company expects to realize annual cost synergies of $5 million with full realization in fiscal 2019.  To finance the purchase, the Company used existing liquidity.

Clopay Plastic Products Company, Inc.

In February 2018, the Company acquired Clopay Plastic Products Company, Inc. ("Clopay") for a purchase price of $475 million.  Clopay is an innovator in the development of printed breathable films, elastic films, and laminates with product offerings uniquely designed for applications used in a number of markets including: hygiene, healthcare, construction and industrial protective apparel.  The acquired business is operated in our Health, Hygiene & Specialties segment.  The Company expects to realize annual cost synergies of $40 million with full realization expected in fiscal 2019.  To finance the purchase, the Company issued $500 million aggregate principle amount of 4.5% second priority notes through a private placement offering.

Raw Material Trends. Our primary raw material is plastic resin consisting primarily of polypropylene and polyethylene. Plastic resins are subject to price fluctuations, including those arising from supply shortages and changes in the prices of natural gas, crude oil and other petrochemical intermediates from which resins are produced. The three month simple average price per pound, as published by U.S. market indexes, was as follows:

	Polyethylene Butene Film						Polypropylene
	2019		2018		2017		2019		2018		2017
1st quarter	$	.64	$	.68	$	.56	$	.76	$	.71	$	.56
2nd quarter		—		.69		.58		—		.75		.67
3rd quarter		—		.68		.60		—		.76		.61
4th quarter		—		.66		.62		—		.85		.62

Due to differences in the timing of passing through resin cost changes to our customers on escalator/de-escalator programs, segments are negatively impacted in the short term when plastic resin costs increase and are positively impacted when plastic resin costs decrease. This timing lag in passing through raw material cost changes could affect our results as plastic resin costs fluctuate. 

19

Outlook.  The Company is affected by general economic and industrial growth, plastic resin availability and affordability, and general industrial production.  Our business has both geographic and end-market diversity, which reduces the effect of any one of these factors on our overall performance.  Our results are affected by our ability to pass through raw material and other cost changes to our customers, improve manufacturing productivity and adapt to volume changes of our customers.  We believe there are long term growth opportunities within the health, pharmaceuticals, personal care and food packaging markets existing outside of North America, especially in Asia, where expected per capita consumption increases should result in organic market growth.  We continue to believe that long term dynamics of resin markets will be advantageous. Planned capacity expansions in polyethylene in North America and recent declines in global oil should benefit the Company.  For fiscal 2019, we project cash flow from operations and adjusted free cash flow of $1,036 million and $670 million, respectively.  The $670 million of adjusted free cash flow includes $350 million of capital spending and $16 million of payments under our tax receivable agreement.  Within our adjusted free cash flow guidance, we are also assuming cash taxes of $149 million, cash interest costs of $270 million, and other cash uses of $45 million related to changes in working capital and items such as acquisition integration expenses and costs to achieve synergies.  For the definition of Adjusted free cash flow and further information related to Adjusted free cash flow as a non-GAAP financial measure, see “Liquidity and Capital Resources.”

Results of Operations

Comparison of the Quarterly Period Ended December 29, 2018 (the "Quarter") and the Quarterly Period Ended December 30, 2017 (the "Prior Quarter")

Acquisition sales and operating income disclosed within this section represents the results from acquisitions for the current period.  Business integration expenses consist of restructuring and impairment charges, acquisition related costs, and other business optimization costs.  Tables present dollars in millions.

Consolidated Overview
	Quarter				Prior Quarter				$ Change			% Change
Net sales		$	1,972			$	1,776			$	196		11	%
Operating income		$	176			$	163			$	13		8	%
Operating income percentage of net sales			9	%			9	%

The net sales increase of $196 million from Prior Quarter is primarily attributed to acquisition net sales of $158 million and organic sales growth of $49 million, partially offset by an $11 million unfavorable impact from foreign currency changes.  The organic sales growth is primarily attributed to increased selling prices of $82 million due to the pass through of higher cost of goods sold, partially offset by a 2% volume decline.

The operating income increase of $13 million from Prior Quarter is primarily attributed to a $10 million decrease in business integration costs, a $6 million decrease in depreciation and amortization, acquisition operating income of $3 million, and a $3 million impact from improvement in price cost spread.  These increases are partially offset by a $4 million unfavorable impact from volume and a $4 million unfavorable impact from foreign currency changes.

Engineered Materials
	Quarter				Prior Quarter				$ Change			% Change
Net sales		$	669			$	648			$	21		3	%
Operating income		$	94			$	88			$	6		7	%
Percentage of net sales			14	%			14	%

Net sales in the Engineered Materials segment increased by $21 million from Prior Quarter primarily attributed to acquisition net sales of $35 million, partially offset by an organic sales decline of $13 million.  The organic sales decline is primarily attributed to a 3% volume decline as the result of strong volumes in the Prior Quarter, offset by increased selling prices of $8 million due to the pass through of higher cost of goods sold.

The operating income increase of $6 million from Prior Quarter is primarily attributed to a $6 million impact from improvement in price cost spread and a $3 million decrease in depreciation and amortization, partially offset by a negative $3 million impact from volume.

Health, Hygiene & Specialties
	Quarter				Prior Quarter				$ Change			% Change
Net sales		$	702			$	577			$	125		22	%
Operating income		$	49			$	37			$	12		32	%
Percentage of net sales			7	%			6	%

20

Net sales in the Health, Hygiene & Specialties segment increased by $125 million from Prior Quarter primarily attributed to acquisition net sales of $123 million and organic sales growth of $12 million, partially offset by a $10 million unfavorable impact from foreign currency changes.  The organic sales growth is primarily attributed to increased selling prices of $39 million due to the pass through of higher cost of goods sold, partially offset by a 5% volume decline as a result of general market softness in hygiene and specialties.

The operating income increase of $12 million from Prior Quarter is primarily attributed to a $10 million decrease in business integration costs, a $6 million impact from improvement in price cost spread, acquisition operating income of $3 million, and a $2 million decrease in depreciation and amortization.  These increases are partially offset by a negative $5 million impact from volume and a $3 million unfavorable impact from foreign currency changes.

Consumer Packaging
	Quarter				Prior Quarter				$ Change				% Change
Net sales		$	601			$	551			$	50			9	%
Operating income		$	33			$	38			$	(5	)		(13	%)
Percentage of net sales			5	%			7	%

Net sales in the Consumer Packaging segment increased by $50 million from Prior Quarter primarily attributed to organic sales growth.  The organic sales growth is primarily attributed to increased selling prices of $35 million due to the pass through of higher cost of goods sold and a 3% volume improvement.

The operating income decrease of $5 million from Prior Quarter is primarily attributed to a negative $9 million impact from under recovery of higher cost of goods sold, partially offset by a favorable $4 million impact from volume.

Other (income) expense, net
	Quarter			Prior Quarter			$ Change				% Change
Other (income) expense, net		$	—		$	9		$	(9	)		100	%

The other (income) expense, net decrease of $9 million from Prior Quarter is primarily attributed to favorable foreign currency changes related to the remeasurement of non-operating intercompany balances.

Interest expense, net
	Quarter			Prior Quarter			$ Change			% Change
Interest expense, net		$	64		$	62		$	2		3	%

The interest expense increase of $2 million from Prior Quarter is primarily attributed to additional expenses from the $500 million 4.5% second priority senior secured notes used to fund the Clopay acquisition, partially offset by lower interest as a result of repayments on long-term borrowings in fiscal 2018.

Income tax expense (benefit)
	Quarter			Prior Quarter				$ Change			% Change
Income tax expense (benefit)		$	24		$	(71	)		$	95		(134	%)

The income tax expense (benefit) decrease of $95 million from Prior Quarter is primarily attributed to an increase in income before taxes and the $95 million provisional transition benefit recorded in the Prior Quarter as a result of U.S. tax reform.  The effective tax rate was 21% for the Quarter and was positively impacted by 2% from the share-based compensation excess tax benefit deduction, 1% from research and development credits, and other discrete items.  These favorable items were offset by increases of 4% from U.S. state income taxes and other discrete items.

Changes in Comprehensive Income

The $84 million decrease in Comprehensive income from Prior Quarter is primarily attributed to a $75 million decline in Net income and a $30 million decrease in the fair value of interest rate hedges, net of tax, partially offset by a $20 million increase in currency translation.  Currency translation gains are primarily related to non-U.S. subsidiaries with a functional currency other than the U.S. Dollar whereby assets and liabilities are translated from the respective functional currency into U.S. Dollars using period-end exchange rates.  The change in currency translation was primarily attributed to locations utilizing the Euro, Brazilian Real, and Canadian Dollar as their functional currency.  As part of the overall risk management, the Company uses derivative instruments to reduce exposure to changes in interest rates attributed to the Company’s floating-rate borrowings and records changes to the fair value of these instruments in Accumulated other comprehensive loss.  The change in fair value of these instruments in fiscal 2019 versus fiscal 2018 is primarily attributed to a change in the forward interest curve between measurement dates.

21

Liquidity and Capital Resources

Senior Secured Credit Facility

We manage our global cash requirements considering (i) available funds among the many subsidiaries through which we conduct business, (ii) the geographic location of our liquidity needs, and (iii) the cost to access international cash balances.  We have a $750 million asset-based revolving line of credit that matures in May 2020.  At the end of the Quarter, the Company had no outstanding balance on the revolving credit facility.  The Company was in compliance with all covenants at the end of the Quarter (see Note 8).

Cash Flows

Net cash from operating activities increased $8 million from the Prior Quarter primarily attributed to improved net income before depreciation, amortization and deferred income taxes, partially offset by an increase in working capital.

Net cash used in investing activities decreased $16 million from the Prior Quarter primarily attributed to decreased capital expenditures compared to the Prior Quarter.

Net cash used in financing activities increased $32 million from the Prior Quarter primarily attributed to share repurchases, partially offset by lower tax receivable agreement payments.

Share Repurchases

We repurchased $54 million of our common stock in the Quarter. Share repurchases were completed using existing liquidity.

Adjusted Free Cash Flow

We define "Adjusted free cash flow" as cash flow from operating activities less net additions to property, plant and equipment and payments of the tax receivable agreement.

Based on our definition, our consolidated adjusted free cash flow is summarized as follows:

	Quarterly Period Ended
	December 29, 2018			December 30, 2017
Cash flow from operating activities	$	161		$	153
Additions to property, plant and equipment, net		(75	)		(91	)
Payments of tax receivable agreement		(16	)		(37	)
Adjusted free cash flow	$	70		$	25

Adjusted free cash flow, as presented in this document, is a supplemental financial measure that is not required by, or presented in accordance with, generally accepted accounting principles in the U.S. ("GAAP").  Adjusted free cash flow is not a GAAP financial measure and should not be considered as an alternative to cash flow from operating activities or any other measure determined in accordance with GAAP.   We use Adjusted free cash flow as a measure of liquidity because it assists us in assessing our company’s ability to fund its growth through its generation of cash, and believe it is useful to investors for such purpose. In addition, Adjusted free cash flow and similar measures are widely used by investors, securities analysts and other interested parties in our industry to measure a company's liquidity.  Adjusted free cash flow may be calculated differently by other companies, including other companies in our industry, limiting its usefulness as a comparative measure.

Liquidity Outlook

At December 29, 2018, our cash balance was $293 million, of which approximately 75% was located outside the U.S.  We believe our existing U.S. based cash and cash flow from U.S. operations, together with available borrowings under our senior secured credit facilities, will be adequate to meet our liquidity needs over the next twelve months.  We do not expect our free cash flow to be sufficient to cover all long-term debt obligations and intend to refinance these obligations prior to maturity.  However, we cannot predict our future results of operations and our ability to meet our obligations involves numerous risks and uncertainties, including, but not limited to, those described in the “Risk Factors” section of our most recent Form 10-K filed with the Securities and Exchange Commission and in this Form 10-Q, if any.

22

Item 3.  Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Sensitivity

We are exposed to market risk from changes in interest rates primarily through our senior secured credit facilities.  As of December 29, 2018, our senior secured credit facilities are comprised of (i) $3.6 billion term loans and (ii) a $750 million revolving credit facility with no borrowings outstanding.  Borrowings under our senior secured credit facilities bear interest at a rate equal to an applicable margin plus LIBOR.  The applicable margin for LIBOR rate borrowings under the revolving credit facility ranges from 1.25% to 1.75%, and the margin for the term loans range from 1.75% to 2.00% per annum.  As of December 29, 2018, the LIBOR rate of approximately 2.50% was applicable to the term loans.  A 0.25% change in LIBOR would increase our annual interest expense by $5 million on variable rate term loans.

We seek to minimize interest rate volatility risk through regular operating and financing activities and, when deemed appropriate, through the use of derivative financial instruments. These financial instruments are not used for trading or other speculative purposes. As of December 29, 2018, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.000%, with an effective date in May 2017 and expiration in May 2022 and (ii) a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date in June 2018 and expiration in September 2021.

Foreign Currency Exchange Rates

As a global company, we face foreign currency risk exposure from fluctuating currency exchange rates, primarily the U.S. dollar against the euro, Brazilian real, Argentine peso, Chinese renminbi, Canadian dollar and Mexican peso.  Significant fluctuations in currency rates can have a substantial impact, either positive or negative, on our revenue, cost of sales, and operating expenses.  Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates and impact our Comprehensive income.  A 10% decline in foreign currency exchange rates would have a negative $6 million impact on our annual Net income.

The Company is party to certain cross-currency swap agreements with a notional amount of 250 million euro to effectively convert a portion of our fixed-rate U.S. dollar denominated term loans, including the monthly interest payments, to fixed-rate euro-denominated debt.  The swap agreements mature May 2022.  The risk management objective is to manage foreign currency risk relating to net investments in certain European subsidiaries denominated in foreign currencies and reduce the variability in the functional currency cash flows of a portion of the Company’s term loans.  In the future, we may attempt to manage our foreign currency risk on our anticipated cash movements by entering into foreign currency forward contracts to offset potential foreign exchange gains or losses.

23

Item 4.  Controls and Procedures

(a) Evaluation of disclosure controls and procedures.

Under applicable Securities and Exchange Commission regulations, management of a reporting company, with the participation of the principal executive officer and principal financial officer, must periodically evaluate the company's "disclosure controls and procedures," which are defined generally as controls and other procedures of a reporting company designed to ensure that information required to be disclosed by the reporting company in its periodic reports filed with the commission (such as this Form 10-Q) is recorded, processed, summarized, and reported on a timely basis.

The Company's management, with the participation of the Chief Executive Officer and the Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the disclosure controls and procedures as of December 29, 2018.  Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 29, 2018, the design and operation of our disclosure controls and procedures were effective at the reasonable assurance level.

(b) Changes in internal controls.

There were no changes in our internal control over financial  reporting that occurred during the quarter ended December 29, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

24

Part II.  Other Information

Item 1.  Legal Proceedings

There have been no material changes in legal proceedings from the items disclosed in our Form 10-K filed with the Securities and Exchange Commission.

Item 1A.  Risk Factors

Before investing in our securities, we recommend that investors carefully consider the risks described in our most recent Form 10-K filed with the Securities and Exchange Commission, including those under the heading "Risk Factors" and other information contained in this Quarterly Report.  Realization of any of these risks could have a material adverse effect on our business, financial condition, cash flows and results of operations.  There were not material changes to the Company's risk factors as described in our most recent Form 10-K filed with the Securities and Exchange Commission.

Forward-looking Statements and Other Factors Affecting Future Results.

All forward-looking information and subsequent written and oral forward-looking statements attributable to us, or to persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements. Some of the factors that we believe could affect our results include: 

● risks associated with our substantial indebtedness and debt service; 

● changes in prices and availability of resin and other raw materials and our ability to pass on changes in raw material prices on a timely basis; 

● performance of our business and future operating results; 

● risks related to acquisitions and integration of acquired businesses; 

● reliance on unpatented proprietary know-how and trade secrets; 

● increases in the cost of compliance with laws and regulations, including environmental, safety, and production and product laws and regulations; 

● risks related to disruptions in the overall economy and the financial markets that may adversely impact our business; 

● risk of catastrophic loss of one of our key manufacturing facilities, natural disasters, and other unplanned business interruptions; 

● risks related to market acceptance of our developing technologies and products;

● general business and economic conditions, particularly an economic downturn; 

● risks that our restructuring programs may entail greater implementation costs or result in lower cost savings than anticipated;

● ability of our insurance to fully cover potential exposures;

● risks of competition, including foreign competition, in our existing and future markets;

● new legislation or new regulations and the Company's corresponding interpretations of either may affect our business and consolidated financial condition and results of operations; and

● the other factors discussed in our most recent Form 10-K and in this Form 10-Q in the section titled "Risk Factors." 

We caution readers that the foregoing list of important factors may not contain all of the material factors that are important to you.  In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this Form 10-Q may not in fact occur.  Accordingly, investors should not place undue reliance on those statements.  We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

25

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Repurchases of Equity Securities

In August 2018, the Company announced a $500 million share repurchase program that has no expiration date and may be suspended at any time.  The following table summarizes the Company's repurchases of its common stock during the Quarterly Period ended December 29, 2018.

Period	Total Number of Shares Purchased		Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Programs		Dollar Value of Shares that May Yet be Purchased Under the Program (in millions)
Fiscal October		212,328	$	44.02		212,328	$	456
Fiscal November		139,094		49.72		139,094		449
Fiscal December		781,015		47.86		781,015		412
Total		1,132,437	$	47.37		1,132,437	$	412

26

Item 6.  Exhibits

Exhibit No.	Description of Exhibit
31.1*	Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
31.2*	Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
32.1*	Section 1350 Certification of the Chief Executive Officer.
32.2*	Section 1350 Certification of the Chief Financial Officer.
101.	Interactive Data Files.

* Filed herewith

27

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Berry Global Group, Inc.
February 1, 2019	By:	/s/ Mark W. Miles
		Mark W. Miles
		Chief Financial Officer

28

EX-31.1

EXHIBIT 31.1

CHIEF EXECUTIVE OFFICER CERTIFICATION

I, Thomas E. Salmon, Chief Executive Officer of Berry Global Group, Inc., certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Berry Global Group, Inc. (the "Registrant");

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.  The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5.  The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

	By:	/s/ Thomas E. Salmon
Date: February 1, 2019		Thomas E. Salmon
		Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

I, Mark W. Miles, Chief Financial Officer of Berry Global Group, Inc., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Berry Global Group, Inc. (the "Registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

	By:	/s/ Mark W. Miles
Date: February 1, 2019		Mark W. Miles
		Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Berry Global Group, Inc. (the "Registrant") on Form 10-Q for the quarter ended December 29, 2018, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Thomas E. Salmon, Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/ Thomas E. Salmon

Thomas E. Salmon

Chief Executive Officer

Date: February 1, 2019

EX-32.2

EXHIBIT 32.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Berry Global Group, Inc. (the "Registrant") on Form 10-Q for the quarter ended December 29, 2018, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mark W. Miles, the Chief Financial Officer and Treasurer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

/s/ Mark W. Miles

Mark W. Miles

Chief Financial Officer

Date: February 1, 2019

XML

Document and Entity Information - shares shares in Millions	3 Months Ended
	Dec. 29, 2018	Feb. 01, 2019
Document And Entity Information [Abstract]
Entity Registrant Name	BERRY GLOBAL GROUP INC
Entity Central Index Key	0001378992
Current Fiscal Year End Date	--09-28
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		130.3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 29, 2018
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1

XML

Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Consolidated Statements of Income (Unaudited) [Abstract]
Net sales	$ 1,972	$ 1,776
Costs and expenses:
Cost of goods sold	1,619	1,447
Selling, general and administrative	124	117
Amortization of intangibles	42	38
Restructuring and impairment charges	11	11
Operating income	176	163
Other (income) expense, net	0	9
Interest expense, net	64	62
Income before income taxes	112	92
Income tax expense (benefit)	24	(71)
Net income	$ 88	$ 163
Net income per share:
Basic (in dollars per share)	$ 0.67	$ 1.24
Diluted (in dollars per share)	$ 0.66	$ 1.20
Outstanding weighted-average shares:
Basic (in shares)	131.1	131.0
Diluted (in shares)	133.8	136.0

XML

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Consolidated Statements of Comprehensive Income (Unaudited) [Abstract]
Net income	$ 88	$ 163
Currency translation	(4)	(24)
Pension and other postretirement benefits	0	(1)
Interest rate hedges	(24)	17
Provision for income taxes	7	(4)
Other comprehensive loss, net of tax	(21)	(12)
Comprehensive income	$ 67	$ 151

XML

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Current assets:
Cash and cash equivalents	$ 293	$ 381
Accounts receivable (less allowance of $13)	879	941
Inventories:
Finished goods	545	503
Raw materials and supplies	411	384
Inventories	956	887
Prepaid expenses and other current assets	78	76
Total current assets	2,206	2,285
Property, plant and equipment, net	2,457	2,488
Goodwill and intangible assets, net	4,243	4,284
Other assets	66	74
Total assets	8,972	9,131
Current liabilities:
Accounts payable	715	783
Accrued expenses and other current liabilities	427	416
Current portion of long-term debt	37	38
Total current liabilities	1,179	1,237
Long-term debt, less current portion	5,700	5,806
Deferred income taxes	357	365
Other long-term liabilities	281	289
Total liabilities	7,517	7,697
Stockholders' equity
Common stock (130.6 and 131.4 million shares issued, respectively)	1	1
Additional paid-in capital	873	867
Non-controlling interest	3	3
Retained earnings	755	719
Accumulated other comprehensive loss	(177)	(156)
Total stockholders' equity	1,455	1,434
Total liabilities and stockholders' equity	$ 8,972	$ 9,131

XML

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) shares in Millions, $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Current assets:
Accounts receivable, allowance	$ 13	$ 13
Stockholders' equity
Common stock, shares issued (in shares)	130.6	131.4

XML

Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Millions	Common Stock [Member]	Additional Paid-in Capital [Member]	Non-Controlling Interest [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Balance at Sep. 30, 2017	$ 1	$ 823	$ 3	$ (68)	$ 256	$ 1,015
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	0	4	0	0	0	4
Proceeds from issuance of common stock	0	4	0	0	0	4
Interest rate hedge, net of tax	0	0	0	13	0	13
Net income attributable to the Company	0	0	0	0	163	163
Currency translation	0	0	0	(24)	0	(24)
Pension	0	0	0	(1)	0	(1)
Balance at Dec. 30, 2017	1	831	3	(80)	419	1,174
Balance at Sep. 29, 2018	1	867	3	(156)	719	1,434
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	0	3	0	0	0	3
Proceeds from issuance of common stock	0	5	0	0	0	5
Common stock repurchased and retired	0	(2)	0	0	(52)	(54)
Interest rate hedge, net of tax	0	0	0	(17)	0	(17)
Net income attributable to the Company	0	0	0	0	88	88
Currency translation	0	0	0	(4)	0	(4)
Balance at Dec. 29, 2018	$ 1	$ 873	$ 3	$ (177)	$ 755	$ 1,455

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Cash Flows from Operating Activities:
Net income	$ 88	$ 163
Adjustments to reconcile net cash provided by operating activities:
Depreciation	96	91
Amortization of intangibles	42	38
Non-cash interest expense	(1)	3
Deferred income tax	4	(121)
Share-based compensation expense	3	4
Other non-cash operating activities, net	4	6
Changes in working capital	(71)	(66)
Changes in other assets and liabilities	(4)	35
Net cash from operating activities	161	153
Cash Flows from Investing Activities:
Additions to property, plant and equipment	(75)	(94)
Proceeds from sale of assets	0	3
Net cash from investing activities	(75)	(91)
Cash Flows from Financing Activities:
Repayments on long-term borrowings	(110)	(108)
Proceeds from issuance of common stock	5	4
Repurchase of common stock	(52)	0
Payment of tax receivable agreement	(16)	(37)
Net cash from financing activities	(173)	(141)
Effect of exchange rate changes on cash	(1)	1
Net change in cash	(88)	(78)
Cash and cash equivalents at beginning of period	381	306
Cash and cash equivalents at end of period	$ 293	$ 228

XML

Basis of Presentation

3 Months Ended

Dec. 29, 2018

Basis of Presentation [Abstract]

Basis of Presentation

1.  Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.  In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period.  Actual results could differ from those estimates.  Certain reclassifications have been made to prior periods to conform to current reporting.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated.  For further information, refer to the Company's most recent Form 10-K filed with the Securities and Exchange Commission.

XML

Recently Issued Accounting Pronouncements

3 Months Ended

Dec. 29, 2018

Recently Issued Accounting Pronouncements [Abstract]

Recently Issued Accounting Pronouncements

2.  Recently Issued Accounting Pronouncements

Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification.  During fiscal 2019, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2018 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements.

Revenue Recognition

In May 2014, the FASB issued a final standard on revenue recognition.  Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein.  An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings.  The Company adopted the new standard effective for fiscal 2019 using the modified retrospective approach.  The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

Leases

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements.  Under the new standard, the lessee of an operating lease will be required to do the following: 1) recognize a right-of-use asset and a lease liability in the statement of financial position, 2) recognize a single lease cost allocated over the lease term generally on a straight-line basis, and 3) classify all cash payments within operating activities on the statement of cash flows.  Companies are required to adopt this standard using a modified retrospective transition method.  Amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years.  The Company is currently evaluating the impact of this standard, which will be effective for the Company beginning fiscal 2020.

XML

Revenue Recognition

3 Months Ended

Dec. 29, 2018

Revenue Recognition [Abstract]

Revenue Recognition

3.  Revenue Recognition

Our revenues are primarily derived from the sale of plastic packaging products to customers.  Revenue is recognized when performance obligations are satisfied, in an amount reflecting the consideration the Company expects to be entitled.  We consider the promise to transfer products to be our sole performance obligation.  If the consideration agreed to in a contract includes a variable amount, we estimate the amount of consideration we expect to be entitled to in exchange for transferring the promised goods to the customer using the most likely amount method.  Our main sources of variable consideration are customer rebates and cash discounts.  There are no material instances where variable consideration is constrained and not recorded at the initial time of sale.  Generally our revenue is recognized at a point in time for standard promised goods at the time of shipment, when title and risk of loss pass to the customer.  A small number of our contracts are for sales of products which are customer specific and cannot be repurposed. Sales for these products qualify for over time recognition and are immaterial to the Company.

Our rebate programs are individually negotiated with customers and contain a variety of different terms and conditions.  Certain rebates are calculated as flat percentages of purchases, while others included tiered volume incentives.  These rebates may be payable monthly, quarterly, or annually.  The calculation of the accrued rebate balance involves management estimates, especially where the terms of the rebate involve tiered volume levels that require estimates of expected annual sales.  These provisions are based on estimates derived from current program requirements and historical experience.  The accrual for customer rebates was $64 million and $58 million at December 29, 2018 and September 29, 2018, respectively, and is included in Accrued expenses and other current liabilities.

Due to the nature of our sales transactions, we have elected the following practical expedients: (i) Shipping and handling costs are treated as fulfillment costs. Accordingly, shipping and handling costs are classified as a component of Cost of goods sold while amounts billed to customers are classified as a component of Net Sales; (ii) We exclude sales and similar taxes that are imposed on our sales and collected from customers; (iii) As our standard payment terms are less than one year, we did not assess whether a contract has a significant financing component.

The Company disaggregates revenue based on reportable business segment, geography, and significant product line.  Refer to Note 11. Operating Segments for further information.

XML

Acquisitions

3 Months Ended

Dec. 29, 2018

Acquisitions [Abstract]

Acquisitions

4.  Acquisitions

Laddawn, Inc.

In August 2018, the Company acquired Laddawn, Inc. ("Laddawn") for a purchase price of $242 million, which is preliminary and subject to adjustment.  Laddawn is a custom bag and film manufacturer with a unique-to-industry e-commerce sales platform.  The acquired business is operated in our Engineered Materials segment.  To finance the purchase, the Company used existing liquidity.

The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary estimates of fair value at the acquisition date.  The results of Laddawn have been included in the consolidated results of the Company since the date of the acquisition.  The Company has not finalized the allocation of the purchase price to the fair value of the assets acquired and liabilities assumed.  The assets acquired and liabilities assumed consisted of working capital of $26 million, property and equipment of $39 million, intangible assets of $98 million, and goodwill of $79 million.  The working capital includes a $2 million step up of inventory to fair value.  The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes.

Clopay Plastic Products Company, Inc.

In February 2018, the Company acquired Clopay Plastic Products Company, Inc. ("Clopay") for a purchase price of $475 million.  Clopay is an innovator in the development of printed breathable films, elastic films, and laminates with product offerings uniquely designed for applications used in a number of markets including: hygiene, healthcare, construction and industrial protective apparel.  The acquired business is operated within our Health, Hygiene & Specialties segment.  To finance the purchase, the Company issued $500 million aggregate principal amount of 4.5% second priority notes through a private placement offering.

The acquisition has been accounted for under the purchase method of accounting, and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on fair values at the acquisition date.  The results of Clopay have been included in the consolidated results of the Company since the date of the acquisition.  The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes.  The following table summarizes the purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5

(a) Includes a $3 million step up of inventory to fair value

XML

Accounts Receivable Factoring Agreements

3 Months Ended

Dec. 29, 2018

Accounts Receivable Factoring Agreements [Abstract]

Accounts Receivable Factoring Agreements

5.  Accounts Receivable Factoring Agreements

The Company has entered into various factoring agreements, both in the U.S. and at a number of foreign subsidiaries, to sell certain receivables to unrelated third-party financial institutions. The Company accounts for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860").  ASC 860 allows for the ownership transfer of accounts receivable to qualify for sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheets.  Receivables are considered sold when (i) they are transferred beyond the reach of the Company and its creditors, (ii) the purchaser has the right to pledge or exchange the receivables, and (iii) the Company has surrendered control over the transferred receivables.  In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold.

There were no amounts outstanding from financial institutions related to U.S. based programs at December 29, 2018 or September 29, 2018.  Gross amounts factored under these U.S. based programs at December 29, 2018 and September 29, 2018 were $212 million and $162 million, respectively.  The fees associated with transfer of receivables for all programs were not material for any of the periods presented.

XML

Restructuring and Impairment Charges

3 Months Ended

Dec. 29, 2018

Restructuring and Impairment Charges [Abstract]

Restructuring and Impairment Charges

6.  Restructuring and Impairment Charges

The Company incurred restructuring costs of $11 million for both the quarterly period ended December 29, 2018 and December 30, 2017, respectively.  The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Consumer Packaging	$	—	$	1
Health, Hygiene & Specialties		10		10
Engineered Materials		1		—
Consolidated	$	11	$	11

The table below sets forth the activity with respect to the restructuring accrual at December 29, 2018:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance at September 29, 2018	$	9			4			—		$	13
Charges		3			1			7			11
Non-cash asset impairment		—			—			(7	)		(7	)
Cash payments		(6	)		(1	)		—			(7	)
Balance at December 29, 2018	$	6			4			—		$	10

XML

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

3 Months Ended

Dec. 29, 2018

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

7.  Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Employee compensation	$	106	$	113
Accrued taxes		79		72
Rebates		64		58
Interest		43		49
Tax receivable agreement obligation		12		16
Restructuring		10		13
Accrued operating expenses		113		95
	$	427	$	416

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Uncertain tax positions	$	68	$	67
Deferred purchase price		43		40
Pension liability		42		45
Lease retirement obligation		40		39
Sale-lease back deferred gain		21		21
Transition tax		18		18
Derivative instruments		13		12
Tax receivable agreement obligation		12		23
Other		24		24
	$	281	$	289

XML

Long-Term Debt

3 Months Ended

Dec. 29, 2018

Long-Term Debt [Abstract]

Long-Term Debt

8.  Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	December 29, 2018			September 29, 2018
Term loan	February 2020	$	700		$	800
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,545
Term loan	January 2024		493			493
Revolving line of credit	May 2020		—			—
5 1/2% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 1/8% Second Priority Senior Secured Notes	July 2023		700			700
4 1/2% Second Priority Senior Secured Notes	February 2026		500			500
Debt discounts and deferred fees			(40	)		(43	)
Capital leases and other	Various		125			135
Total long-term debt			5,737			5,844
Current portion of long-term debt			(37	)		(38	)
Long-term debt, less current portion		$	5,700		$	5,806

The Company was in compliance with all debt covenants for all periods presented.

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense through maturity.

Term Loans

The term loans with a maturity date of February 2020 and January 2021 bear interest at LIBOR plus 1.75%.  The term loans with a maturity date of October 2022 and January 2024 bear interest at LIBOR plus 2.00%.

During fiscal 2019, the Company has made $110 million of repayments on long-term borrowings using existing liquidity.

XML

Financial Instruments and Fair Value Measurements

3 Months Ended

Dec. 29, 2018

Financial Instruments and Fair Value Measurements [Abstract]

Financial Instruments and Fair Value Measurements

9.  Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors.  The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies.  These financial instruments are not used for trading or other speculative purposes.  For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

To the extent hedging relationships are found to be effective, as determined by FASB guidance, changes in the fair value of the derivatives are offset by changes in the fair value of the related hedged item and recorded to Accumulated other comprehensive loss. Any identified ineffectiveness, or changes in the fair value of a derivative not designated as a hedge, is recorded to the Consolidated Statements of Income.

Cross-Currency Swaps

The Company is party to certain cross-currency swap agreements with a notional amount of 250 million euro to effectively convert a portion of our fixed-rate U.S. dollar denominated term loans, including the monthly interest payments, to fixed-rate euro-denominated debt.  The swap agreements mature in May 2022.  The risk management objective is to manage foreign currency risk relating to net investments in certain European subsidiaries denominated in foreign currencies and reduce the variability in the functional currency cash flows of a portion of the Company’s term loans.  Changes in fair value of the derivative instruments are recognized in a component of Accumulated other comprehensive loss, to offset the changes in the values of the net investments being hedged.

Interest Rate Swaps

The primary purpose of the Company’s interest rate swap activities is to manage cash flow variability associated with our outstanding variable rate term loan debt.

During fiscal 2017 the Company modified various term loan rates and maturities.  In conjunction with these modifications the Company realigned existing swap agreements which resulted in the de-designation of the original hedge and re-designation of the modified swaps as effective cash flow hedges.  The amounts included in Accumulated other comprehensive loss at the date of de-designation are being amortized to Interest expense through the terms of the original swaps.

As of December 29, 2018, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.000%, with an effective date in May 2017 and expiration in May 2022 and (ii) a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date in June 2018 and expiration in September 2021.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized.  Balances on a gross basis are as follows:

Derivatives Instruments	Hedge Designation	Balance Sheet Location	December 29, 2018		September 29, 2018
Cross-currency swaps	Designated	Other long-term liabilities	$	3	$	11
Interest rate swaps	Designated	Other assets		7		16
Interest rate swaps	Designated	Other long-term liabilities		10		—
Interest rate swaps	Not designated	Other long-term liabilities		—		1

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended
Derivatives instruments	Statement of Operations Location	December 29, 2018			December 30, 2017
Foreign currency swaps	Other (income) expense, net	$	(4	)	$	2
Interest rate swaps	Interest expense, net		(2	)		(1	)

The amortization related to unrealized losses in Accumulated other comprehensive loss is expected to be $9 million in the next 12 months.

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition.  The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values.  The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value.  These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment.  The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist.  The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2018 assessment.  No impairment indicators were identified in the current quarter.

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of December 29, 2018 and September 29, 2018, along with the impairment loss recognized on the fair value measurement during the period:

	As of December 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,941		2,941		—
Definite lived intangible assets		—		—		1,054		1,054		—
Property, plant, and equipment		—		—		2,457		2,457		7
Total	$	—	$	—	$	6,700	$	6,700	$	7

	As of September 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant, and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	—

The Company's financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, and capital lease obligations.  The book value of our long-term indebtedness exceeded fair value by $45 million as of December 29, 2018.  The Company's long-term debt fair values were determined using Level 2 inputs as other significant observable inputs were not available.

XML

Income Taxes

3 Months Ended

Dec. 29, 2018

Income Taxes [Abstract]

Income Taxes

10.  Income Taxes

In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”).  The transitional impacts of the Tax Act resulted in a transition benefit of $95 million in the quarterly period ended December 30, 2017.  During the Quarter, the Company completed the accounting for the Tax Act, resulting in an immaterial change from fiscal 2018.

The effective tax rate was 21% for the quarterly period ended December 29, 2018 and was positively impacted by 2% from the share-based compensation excess tax benefit deduction, 1% from research and development credits, and other discrete items.  These favorable items were offset by increases of 4% from U.S. state income taxes and other discrete items.

XML

Operating Segments

3 Months Ended

Dec. 29, 2018

Operating Segments [Abstract]

Operating Segments

11.  Operating Segments

The Company's operations are organized into three operating segments: Engineered Materials, Health, Hygiene & Specialties, and Consumer Packaging.  The structure is designed to align us with our customers, provide optimal service, and drive future growth in a cost efficient manner.  Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales:
Engineered Materials	$	669	$	648
Health, Hygiene & Specialties		702		577
Consumer Packaging		601		551
Total net sales	$	1,972	$	1,776
Operating income:
Engineered Materials	$	94	$	88
Health, Hygiene & Specialties		49		37
Consumer Packaging		33		38
Total operating income	$	176	$	163
Depreciation and amortization:
Engineered Materials	$	31	$	29
Health, Hygiene & Specialties		54		46
Consumer Packaging		53		54
Total depreciation and amortization	$	138	$	129

	December 29, 2018		September 29, 2018
Total assets:
Engineered Materials	$	1,964	$	1,998
Health, Hygiene & Specialties		3,811		3,913
Consumer Packaging		3,197		3,220
Total assets	$	8,972	$	9,131
Total goodwill:
Engineered Materials	$	630	$	633
Health, Hygiene & Specialties		903		902
Consumer Packaging		1,408		1,409
Total goodwill	$	2,941	$	2,944

Selected information by geography is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales:
North America	$	1,605	$	1,466
South America		96		74
Europe		204		170
Asia		67		66
Total net sales	$	1,972	$	1,776

	December 29, 2018		September 29, 2018
Long-lived assets:
North America	$	5,685	$	5,764
South America		332		320
Europe		451		463
Asia		298		299
Total long-lived assets:	$	6,766	$	6,846

Selected information by product line is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018			December 30, 2017
Net sales:
Performance Materials		39			43
Engineered Products		61			57
Engineered Materials		100	%		100	%
Health		18			19
Hygiene		52			44
Specialties		30			37
Health, Hygiene & Specialties		100	%		100	%
Rigid Open Top		44			43
Rigid Closed Top		56			57
Consumer Packaging		100	%		100	%

XML

Contingencies and Commitments

3 Months Ended

Dec. 29, 2018

Contingencies and Commitments [Abstract]

Contingencies and Commitments

12.  Contingencies and Commitments

The Company is party to various legal proceedings involving routine claims which are incidental to its business.  Although the Company's legal and financial liability with respect to such proceedings cannot be estimated with certainty, management believes that any ultimate liability would not be material to its financial statements.

The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

XML

Share Repurchase Program

3 Months Ended

Dec. 29, 2018

Share Repurchase Program [Abstract]

Share Repurchase Program

13.  Share Repurchase Program

In fiscal 2018, the Company announced a $500 million share repurchase program.  Berry may repurchase shares through the open market, privately negotiated transactions, or other programs, subject to market conditions.  This authorization has no expiration date and may be suspended at any time.

During the quarterly period ended December 29, 2018, the Company repurchased approximately 1,132 thousand shares for $54 million.  As of December 29, 2018, $412 million of authorized share repurchases remain available to the Company.

XML

Basic and Diluted Net Income Per Share

3 Months Ended

Dec. 29, 2018

Basic and Diluted Net Income Per Share [Abstract]

Basic and Diluted Net Income Per Share

14.  Basic and Diluted Net Income Per Share

Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents.  Diluted net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method.  For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive.  For the three months ended December 29, 2018, 3 million shares were excluded from the diluted net income per share calculation as their effect would be anti-dilutive.

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations:

	Quarterly Period Ended
(in millions, except per share amounts)	December 29, 2018		December 30, 2017
Numerator
Consolidated net income	$	88	$	163
Denominator
Weighted average common shares outstanding - basic		131.1		131.0
Dilutive shares		2.7		5.0
Weighted average common and common equivalent shares outstanding - diluted		133.8		136.0
Per common share income
Basic	$	0.67	$	1.24
Diluted	$	0.66	$	1.20

XML

Accumulated Other Comprehensive Loss

3 Months Ended

Dec. 29, 2018

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

15.  Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 29, 2018	$	(175	)	$	(13	)	$	32		$	(156	)
Other comprehensive income (loss) before reclassifications		(4	)		—			(22	)		(26	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(2	)		(2	)
Provision for income taxes		—			—			7			7
Balance at December 29, 2018	$	(179	)	$	(13	)	$	15		$	(177	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 30, 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss) before reclassifications		(24	)		(1	)		14			(11	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			3			3
Provision for income taxes		—			—			(4	)		(4	)
Balance at December 30, 2017	$	(72	)	$	(17	)	$	9		$	(80	)

XML

Guarantor and Non-Guarantor Financial Information

3 Months Ended

Dec. 29, 2018

Guarantor and Non-Guarantor Financial Information [Abstract]

Guarantor and Non-Guarantor Financial Information

16.  Guarantor and Non-Guarantor Financial Information

Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this Note, “Parent”) and substantially all of Issuer’s domestic subsidiaries.  Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis.  A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances:  the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other indebtedness of the issuer.  The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company’s debts.  Parent also guarantees the Issuer’s term loans and revolving credit facilities.  The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility.  Presented below is condensed consolidating financial information for the Parent, Issuer, guarantor subsidiaries and non-guarantor subsidiaries.  The Issuer and guarantor financial information includes all of our domestic operating subsidiaries; our non-guarantor subsidiaries include our foreign subsidiaries, certain immaterial domestic subsidiaries and the unrestricted subsidiaries under the Issuer’s indentures.  The Parent uses the equity method to account for its ownership in the Issuer in the Condensed Consolidating Supplemental Financial Statements.  The Issuer uses the equity method to account for its ownership in the guarantor and non-guarantor subsidiaries.  All consolidating entries are included in the eliminations column along with the elimination of intercompany balances.

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	141		$	1,377	$	454		$	—		$	1,972
Cost of goods sold		—			85			1,142		392			—			1,619
Selling, general and administrative		—			13			87		24			—			124
Amortization of intangibles		—			—			36		6			—			42
Restructuring and impairment charges		—			—			7		4			—			11
Operating income		—			43			105		28			—			176
Other expense (income), net		—			1			1		(2	)		—			—
Interest expense, net		—			5			45		14			—			64
Equity in net income of subsidiaries		(112	)		(67	)		—		—			179			—
Income before income taxes		112			104			59		16			(179	)		112
Income tax expense		24			16			—		8			(24	)		24
Net income	$	88		$	88		$	59	$	8		$	(155	)	$	88
Comprehensive net income	$	88		$	79		$	59	$	(4	)	$	(155	)	$	67

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	138		$	1,225	$	413		$	—		$	1,776
Cost of goods sold		—			106			989		352			—			1,447
Selling, general and administrative		—			12			80		25			—			117
Amortization of intangibles		—			—			31		7			—			38
Restructuring and impairment charges		—			—			7		4			—			11
Operating income (loss)		—			20			118		25			—			163
Other income, net		—			5			7		(3	)		—			9
Interest expense, net		—			5			43		14			—			62
Equity in net income of subsidiaries		(92	)		(72	)		—		—			164			—
Income before income taxes		92			82			68		14			(164	)		92
Income tax expense		(71	)		(81	)		—		10			71			(71	)
Net income	$	163		$	163		$	68	$	4		$	(235	)	$	163
Comprehensive net income	$	163		$	160		$	68	$	(5	)	$	(235	)	$	151

Condensed Supplemental Consolidated Balance Sheets

	December 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		214		1,243		749		—			2,206
Intercompany receivable		248		1,878		—		28		(2,154	)		—
Property, plant, and equipment, net		—		79		1,660		718		—			2,457
Other assets		1,593		6,326		4,808		486		(8,904	)		4,309
Total assets	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972
Current liabilities		18		248		621		292		—			1,179
Intercompany payable		—		—		2,154		—		(2,154	)		—
Other long-term liabilities		368		5,851		58		61		—			6,338
Stockholders' equity		1,455		2,398		4,878		1,628		(8,904	)		1,455
Total liabilities and stockholders' equity	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972

	September 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		249		1,240		796		—			2,285
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Other assets		1,544		6,247		4,849		487		(8,769	)		4,358
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131
Current liabilities		18		218		635		366		—			1,237
Intercompany payable		—		—		2,252		—		(2,252	)		—
Other long-term liabilities		388		5,945		68		59		—			6,460
Stockholders' equity		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and stockholders' equity	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Statements of Cash Flows

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	55		$	155		$	(49	)	$	—		$	161
Cash Flow from Investing Activities
Additions to  property, plant, and equipment		—			—			(59	)		(16	)		—			(75	)
Proceeds from sale of assets		—			—			—			—			—			—
(Contributions) distributions to/from subsidiaries		47			(47	)		—			—			—			—
Intercompany advances (repayments)		—			38			—			—			(38	)		—
Net cash from investing activities		47			(9	)		(59	)		(16	)		(38	)		(75	)
Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(108	)		(2	)		—			—			(110	)
Proceeds from issuance of common stock		5			—			—			—			—			5
Repurchase of common stock		(52	)		—			—			—			—			(52	)
Payment of tax receivable agreement		(16	)		—			—			—			—			(16	)
Changes in intercompany balances		16			—			(93	)		39			38			—
Net cash from financing activities		(47	)		(108	)		(95	)		39			38			(173	)
Effect of exchange rate changes on cash		—			—			—			(1	)		—			(1	)
Net change in cash		—			(62	)		1			(27	)		—			(88	)
Cash and cash equivalents at beginning of period		—			133			4			244			—			381
Cash and cash equivalents at end of period	$	—		$	71		$	5		$	217		$	—		$	293

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	35		$	139		$	(21	)	$	—		$	153
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(3	)		(61	)		(30	)		—			(94	)
Proceeds from sale of assets		—			—			—			3			—			3
(Contributions) distributions to/from subsidiaries		(4	)		4			—			—			—			—
Intercompany advances (repayments)		—			69			—			—			(69	)		—
Other investing activities, net		—			—			—			—			—			—
Net cash from investing activities		(4	)		70			(61	)		(27	)		(69	)		(91	)
Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(106	)		(2	)		—			—			(108	)
Proceeds from issuance of common stock		4			—			—			—			—			4
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Changes in intercompany balances		37			—			(86	)		(20	)		69			—
Net cash from financing activities		4			(106	)		(88	)		(20	)		69			(141	)
Effect of exchange rate changes on cash		—			—			—			1			—			1
Net change in cash		—			(1	)		(10	)		(67	)		—			(78	)
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	17		$	2		$	209		$	—		$	228

XML

Basis of Presentation (Policies)

3 Months Ended

Dec. 29, 2018

Basis of Presentation [Abstract]

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

Use of Estimates

In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period.  Actual results could differ from those estimates.

Reclassifications

Certain reclassifications have been made to prior periods to conform to current reporting.

XML

Recently Issued Accounting Pronouncements (Policies)

3 Months Ended

Dec. 29, 2018

Recently Issued Accounting Pronouncements [Abstract]

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification.  During fiscal 2019, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2018 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements.

Revenue Recognition

In May 2014, the FASB issued a final standard on revenue recognition.  Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein.  An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings.  The Company adopted the new standard effective for fiscal 2019 using the modified retrospective approach.  The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

Leases

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements.  Under the new standard, the lessee of an operating lease will be required to do the following: 1) recognize a right-of-use asset and a lease liability in the statement of financial position, 2) recognize a single lease cost allocated over the lease term generally on a straight-line basis, and 3) classify all cash payments within operating activities on the statement of cash flows.  Companies are required to adopt this standard using a modified retrospective transition method.  Amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years.  The Company is currently evaluating the impact of this standard, which will be effective for the Company beginning fiscal 2020.

XML

Acquisitions (Tables)

3 Months Ended

Dec. 29, 2018

Acquisitions [Abstract]

Purchase Price Allocation

The following table summarizes the purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5

(a) Includes a $3 million step up of inventory to fair value

XML

Restructuring and Impairment Charges (Tables)

3 Months Ended

Dec. 29, 2018

Restructuring and Impairment Charges [Abstract]

Restructuring Charges by Segment

The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Consumer Packaging	$	—	$	1
Health, Hygiene & Specialties		10		10
Engineered Materials		1		—
Consolidated	$	11	$	11

Restructuring Accrual Activity

The table below sets forth the activity with respect to the restructuring accrual at December 29, 2018:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance at September 29, 2018	$	9			4			—		$	13
Charges		3			1			7			11
Non-cash asset impairment		—			—			(7	)		(7	)
Cash payments		(6	)		(1	)		—			(7	)
Balance at December 29, 2018	$	6			4			—		$	10

XML

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities (Tables)

3 Months Ended

Dec. 29, 2018

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses and Other Current Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Employee compensation	$	106	$	113
Accrued taxes		79		72
Rebates		64		58
Interest		43		49
Tax receivable agreement obligation		12		16
Restructuring		10		13
Accrued operating expenses		113		95
	$	427	$	416

Other Long-Term Liabilities

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	December 29, 2018		September 29, 2018
Uncertain tax positions	$	68	$	67
Deferred purchase price		43		40
Pension liability		42		45
Lease retirement obligation		40		39
Sale-lease back deferred gain		21		21
Transition tax		18		18
Derivative instruments		13		12
Tax receivable agreement obligation		12		23
Other		24		24
	$	281	$	289

XML

Long-Term Debt (Tables)

3 Months Ended

Dec. 29, 2018

Long-Term Debt [Abstract]

Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	December 29, 2018			September 29, 2018
Term loan	February 2020	$	700		$	800
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,545
Term loan	January 2024		493			493
Revolving line of credit	May 2020		—			—
5 1/2% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 1/8% Second Priority Senior Secured Notes	July 2023		700			700
4 1/2% Second Priority Senior Secured Notes	February 2026		500			500
Debt discounts and deferred fees			(40	)		(43	)
Capital leases and other	Various		125			135
Total long-term debt			5,737			5,844
Current portion of long-term debt			(37	)		(38	)
Long-term debt, less current portion		$	5,700		$	5,806

XML

Financial Instruments and Fair Value Measurements (Tables)

3 Months Ended

Dec. 29, 2018

Financial Instruments and Fair Value Measurements [Abstract]

Fair Value of Derivatives and Location on Consolidated Balance Sheets

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized.  Balances on a gross basis are as follows:

Derivatives Instruments	Hedge Designation	Balance Sheet Location	December 29, 2018		September 29, 2018
Cross-currency swaps	Designated	Other long-term liabilities	$	3	$	11
Interest rate swaps	Designated	Other assets		7		16
Interest rate swaps	Designated	Other long-term liabilities		10		—
Interest rate swaps	Not designated	Other long-term liabilities		—		1

Effect of Derivatives on Consolidated Statements of Income

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended
Derivatives instruments	Statement of Operations Location	December 29, 2018			December 30, 2017
Foreign currency swaps	Other (income) expense, net	$	(4	)	$	2
Interest rate swaps	Interest expense, net		(2	)		(1	)

Assets Measured at Fair Value on Non-recurring Basis

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of December 29, 2018 and September 29, 2018, along with the impairment loss recognized on the fair value measurement during the period:

	As of December 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,941		2,941		—
Definite lived intangible assets		—		—		1,054		1,054		—
Property, plant, and equipment		—		—		2,457		2,457		7
Total	$	—	$	—	$	6,700	$	6,700	$	7

	As of September 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant, and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	—

XML

Operating Segments (Tables)

3 Months Ended

Dec. 29, 2018

Operating Segments [Abstract]

Selected Information by Reportable Segment

Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales:
Engineered Materials	$	669	$	648
Health, Hygiene & Specialties		702		577
Consumer Packaging		601		551
Total net sales	$	1,972	$	1,776
Operating income:
Engineered Materials	$	94	$	88
Health, Hygiene & Specialties		49		37
Consumer Packaging		33		38
Total operating income	$	176	$	163
Depreciation and amortization:
Engineered Materials	$	31	$	29
Health, Hygiene & Specialties		54		46
Consumer Packaging		53		54
Total depreciation and amortization	$	138	$	129

	December 29, 2018		September 29, 2018
Total assets:
Engineered Materials	$	1,964	$	1,998
Health, Hygiene & Specialties		3,811		3,913
Consumer Packaging		3,197		3,220
Total assets	$	8,972	$	9,131
Total goodwill:
Engineered Materials	$	630	$	633
Health, Hygiene & Specialties		903		902
Consumer Packaging		1,408		1,409
Total goodwill	$	2,941	$	2,944

Selected Information by Geography

Selected information by geography is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018		December 30, 2017
Net sales:
North America	$	1,605	$	1,466
South America		96		74
Europe		204		170
Asia		67		66
Total net sales	$	1,972	$	1,776

	December 29, 2018		September 29, 2018
Long-lived assets:
North America	$	5,685	$	5,764
South America		332		320
Europe		451		463
Asia		298		299
Total long-lived assets:	$	6,766	$	6,846

Selected Information by Product Line

Selected information by product line is presented in the following tables:

	Quarterly Period Ended
	December 29, 2018			December 30, 2017
Net sales:
Performance Materials		39			43
Engineered Products		61			57
Engineered Materials		100	%		100	%
Health		18			19
Hygiene		52			44
Specialties		30			37
Health, Hygiene & Specialties		100	%		100	%
Rigid Open Top		44			43
Rigid Closed Top		56			57
Consumer Packaging		100	%		100	%

XML

Basic and Diluted Net Income Per Share (Tables)

3 Months Ended

Dec. 29, 2018

Basic and Diluted Net Income Per Share [Abstract]

Basic and Diluted Net Income Per Share

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations:

	Quarterly Period Ended
(in millions, except per share amounts)	December 29, 2018		December 30, 2017
Numerator
Consolidated net income	$	88	$	163
Denominator
Weighted average common shares outstanding - basic		131.1		131.0
Dilutive shares		2.7		5.0
Weighted average common and common equivalent shares outstanding - diluted		133.8		136.0
Per common share income
Basic	$	0.67	$	1.24
Diluted	$	0.66	$	1.20

XML

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Dec. 29, 2018

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 29, 2018	$	(175	)	$	(13	)	$	32		$	(156	)
Other comprehensive income (loss) before reclassifications		(4	)		—			(22	)		(26	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(2	)		(2	)
Provision for income taxes		—			—			7			7
Balance at December 29, 2018	$	(179	)	$	(13	)	$	15		$	(177	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 30, 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss) before reclassifications		(24	)		(1	)		14			(11	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			3			3
Provision for income taxes		—			—			(4	)		(4	)
Balance at December 30, 2017	$	(72	)	$	(17	)	$	9		$	(80	)

XML

Guarantor and Non-Guarantor Financial Information (Tables)

3 Months Ended

Dec. 29, 2018

Guarantor and Non-Guarantor Financial Information [Abstract]

Condensed Supplemental Consolidated Financial Information

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	141		$	1,377	$	454		$	—		$	1,972
Cost of goods sold		—			85			1,142		392			—			1,619
Selling, general and administrative		—			13			87		24			—			124
Amortization of intangibles		—			—			36		6			—			42
Restructuring and impairment charges		—			—			7		4			—			11
Operating income		—			43			105		28			—			176
Other expense (income), net		—			1			1		(2	)		—			—
Interest expense, net		—			5			45		14			—			64
Equity in net income of subsidiaries		(112	)		(67	)		—		—			179			—
Income before income taxes		112			104			59		16			(179	)		112
Income tax expense		24			16			—		8			(24	)		24
Net income	$	88		$	88		$	59	$	8		$	(155	)	$	88
Comprehensive net income	$	88		$	79		$	59	$	(4	)	$	(155	)	$	67

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	138		$	1,225	$	413		$	—		$	1,776
Cost of goods sold		—			106			989		352			—			1,447
Selling, general and administrative		—			12			80		25			—			117
Amortization of intangibles		—			—			31		7			—			38
Restructuring and impairment charges		—			—			7		4			—			11
Operating income (loss)		—			20			118		25			—			163
Other income, net		—			5			7		(3	)		—			9
Interest expense, net		—			5			43		14			—			62
Equity in net income of subsidiaries		(92	)		(72	)		—		—			164			—
Income before income taxes		92			82			68		14			(164	)		92
Income tax expense		(71	)		(81	)		—		10			71			(71	)
Net income	$	163		$	163		$	68	$	4		$	(235	)	$	163
Comprehensive net income	$	163		$	160		$	68	$	(5	)	$	(235	)	$	151

Condensed Supplemental Consolidated Balance Sheets

	December 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		214		1,243		749		—			2,206
Intercompany receivable		248		1,878		—		28		(2,154	)		—
Property, plant, and equipment, net		—		79		1,660		718		—			2,457
Other assets		1,593		6,326		4,808		486		(8,904	)		4,309
Total assets	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972
Current liabilities		18		248		621		292		—			1,179
Intercompany payable		—		—		2,154		—		(2,154	)		—
Other long-term liabilities		368		5,851		58		61		—			6,338
Stockholders' equity		1,455		2,398		4,878		1,628		(8,904	)		1,455
Total liabilities and stockholders' equity	$	1,841	$	8,497	$	7,711	$	1,981	$	(11,058	)	$	8,972

	September 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Total
Current assets		—		249		1,240		796		—			2,285
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Other assets		1,544		6,247		4,849		487		(8,769	)		4,358
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131
Current liabilities		18		218		635		366		—			1,237
Intercompany payable		—		—		2,252		—		(2,252	)		—
Other long-term liabilities		388		5,945		68		59		—			6,460
Stockholders' equity		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and stockholders' equity	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Statements of Cash Flows

	Quarterly Period Ended December 29, 2018
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	55		$	155		$	(49	)	$	—		$	161
Cash Flow from Investing Activities
Additions to  property, plant, and equipment		—			—			(59	)		(16	)		—			(75	)
Proceeds from sale of assets		—			—			—			—			—			—
(Contributions) distributions to/from subsidiaries		47			(47	)		—			—			—			—
Intercompany advances (repayments)		—			38			—			—			(38	)		—
Net cash from investing activities		47			(9	)		(59	)		(16	)		(38	)		(75	)
Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(108	)		(2	)		—			—			(110	)
Proceeds from issuance of common stock		5			—			—			—			—			5
Repurchase of common stock		(52	)		—			—			—			—			(52	)
Payment of tax receivable agreement		(16	)		—			—			—			—			(16	)
Changes in intercompany balances		16			—			(93	)		39			38			—
Net cash from financing activities		(47	)		(108	)		(95	)		39			38			(173	)
Effect of exchange rate changes on cash		—			—			—			(1	)		—			(1	)
Net change in cash		—			(62	)		1			(27	)		—			(88	)
Cash and cash equivalents at beginning of period		—			133			4			244			—			381
Cash and cash equivalents at end of period	$	—		$	71		$	5		$	217		$	—		$	293

	Quarterly Period Ended December 30, 2017
	Parent			Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	35		$	139		$	(21	)	$	—		$	153
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(3	)		(61	)		(30	)		—			(94	)
Proceeds from sale of assets		—			—			—			3			—			3
(Contributions) distributions to/from subsidiaries		(4	)		4			—			—			—			—
Intercompany advances (repayments)		—			69			—			—			(69	)		—
Other investing activities, net		—			—			—			—			—			—
Net cash from investing activities		(4	)		70			(61	)		(27	)		(69	)		(91	)
Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(106	)		(2	)		—			—			(108	)
Proceeds from issuance of common stock		4			—			—			—			—			4
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Changes in intercompany balances		37			—			(86	)		(20	)		69			—
Net cash from financing activities		4			(106	)		(88	)		(20	)		69			(141	)
Effect of exchange rate changes on cash		—			—			—			1			—			1
Net change in cash		—			(1	)		(10	)		(67	)		—			(78	)
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	17		$	2		$	209		$	—		$	228

XML

Revenue Recognition (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Revenue Recognition [Abstract]
Accrual for customer rebates	$ 64	$ 58

XML

Acquisitions, Laddawn, Inc. (Details) - USD ($) $ in Millions	Aug. 31, 2018	Dec. 29, 2018	Sep. 29, 2018
Acquisitions [Abstract]
Goodwill		$ 2,941	$ 2,944
Laddawn [Member]
Acquisitions [Abstract]
Purchase price	$ 242
Working capital	26
Property and equipment	39
Intangible assets	98
Goodwill	79
Step up of inventory to fair value	$ 2

XML

Acquisitions, Clopay Plastic Products Company, Inc. (Details) - USD ($) $ in Millions		Feb. 28, 2018	Dec. 29, 2018	Sep. 29, 2018	Jan. 31, 2018
Allocation of Purchase Price [Abstract]
Goodwill			$ 2,941	$ 2,944
4.50% Second Priority Senior Secured Notes due 2026 [Member]
Acquisitions [Abstract]
Face amount of debt issued					$ 500
Interest rate					4.50%
Clopay [Member]
Acquisitions [Abstract]
Purchase price		$ 475
Allocation of Purchase Price [Abstract]
Working capital	[1]	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5
Step up of inventory to fair value		$ 3

[1] Includes a $3 million step up of inventory to fair value.

XML

Accounts Receivable Factoring Agreements (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Accounts Receivable Factoring Agreements [Abstract]
Amounts due from financial institutions	$ 0	$ 0
Trade receivables sold to financial institutions	$ 212	$ 162

XML

Restructuring and Impairment Charges, Restructuring Charges by Segment (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Restructuring Charges [Abstract]
Restructuring charges	$ 11	$ 11
Consumer Packaging [Member]
Restructuring Charges [Abstract]
Restructuring charges	0	1
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Restructuring charges	10	10
Engineered Materials [Member]
Restructuring Charges [Abstract]
Restructuring charges	$ 1	$ 0

XML

Restructuring and Impairment Charges, Restructuring Accrual Activity (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Sep. 29, 2018
Restructuring Accrual [Roll Forward]
Beginning balance	$ 13
Charges	11	$ 11
Non-cash asset impairment	(7)		$ 0
Cash payments	(7)
Ending balance	10		13
Employee Severance and Benefits [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	9
Charges	3
Non-cash asset impairment	0
Cash payments	(6)
Ending balance	6		9
Facility Exit Costs [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	4
Charges	1
Non-cash asset impairment	0
Cash payments	(1)
Ending balance	4		4
Non-Cash Impairment Charges [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	0
Charges	7
Non-cash asset impairment	(7)
Cash payments	0
Ending balance	$ 0		$ 0

XML

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Employee compensation	$ 106	$ 113
Accrued taxes	79	72
Rebates	64	58
Interest	43	49
Tax receivable agreement obligation	12	16
Restructuring	10	13
Accrued operating expenses	113	95
Accrued expenses and other current liabilities	$ 427	$ 416

XML

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Other Long-Term Liabilities (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Uncertain tax positions	$ 68	$ 67
Deferred purchase price	43	40
Pension liability	42	45
Lease retirement obligation	40	39
Sale-lease back deferred gain	21	21
Transition tax	18	18
Derivative instruments	13	12
Tax receivable agreement obligation	12	23
Other	24	24
Other long-term liabilities	$ 281	$ 289

XML

Long-Term Debt, Summary of Long-Term Debt (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Sep. 29, 2018
Long-term Debt [Abstract]
Debt discounts and deferred fees	$ (40)	$ (43)
Capital leases and other	125	135
Total long-term debt	5,737	5,844
Current portion of long-term debt	(37)	(38)
Long-term debt, less current portion	5,700	5,806
Term Loan due February 2020 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 700	800
Maturity date	Feb. 29, 2020
Term Loan due January 2021 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 814	814
Maturity date	Jan. 31, 2021
Term Loan due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 1,545	1,545
Maturity date	Oct. 31, 2022
Term Loan due January 2024 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 493	493
Maturity date	Jan. 31, 2024
Revolving Line of Credit [Member]
Long-term Debt [Abstract]
Long-term debt	$ 0	0
Maturity date	May 31, 2020
5 1/2% Second Priority Senior Secured Notes due May 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 500	500
Interest rate	5.50%
Maturity date	May 31, 2022
6% Second Priority Senior Secured Notes due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 400	400
Interest rate	6.00%
Maturity date	Oct. 31, 2022
5 1/8% Second Priority Senior Secured Notes due July 2023 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 700	700
Interest rate	5.125%
Maturity date	Jul. 31, 2023
4 1/2% Second Priority Senior Secured Notes due February 2026 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 500	$ 500
Interest rate	4.50%
Maturity date	Feb. 28, 2026

XML

Long-Term Debt, Term Loans (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Long-Term Debt [Abstract]
Repayment of long-term borrowings	$ 110	$ 108
Term Loan due February 2020 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	1.75%
Term Loan due January 2021 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	1.75%
Term Loan due October 2022 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	2.00%
Term Loan due January 2024 [Member] | LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	2.00%

XML

Financial Instruments and Fair Value Measurements, Cross-Currency and Interest Rate Swaps (Details) € in Millions, $ in Millions	3 Months Ended
	Dec. 29, 2018 USD ($)	Dec. 29, 2018 EUR (€)
Cross-Currency Swaps [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap | €		€ 250
Interest Rate Swap - May 2017 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap	$ 450
Fixed annual rate of swap	2.00%	2.00%
Interest Rate Swap - May 2017 [Member] | LIBOR [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Term of variable rate	1 month
Interest Rate Swap - June 2018 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap	$ 1,000
Fixed annual rate of swap	2.808%	2.808%
Interest Rate Swap - June 2018 [Member] | LIBOR [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Term of variable rate	1 month

XML

Financial Instruments and Fair Value Measurements, Fair Value of Derivative and Location on Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018
Cross-Currency Swaps [Member] | Designated [Member] | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 3	$ 11
Interest Rate Swaps [Member] | Designated [Member] | Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	7	16
Interest Rate Swaps [Member] | Designated [Member] | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	10	0
Interest Rate Swaps [Member] | Not Designated [Member] | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 0	$ 1

XML

Financial Instruments and Fair Value Measurements, Effect of Derivatives on Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Derivative Instruments [Abstract]
Amortization related to unrealized losses in Accumulated other comprehensive loss for next 12 months	$ 9
Foreign Currency Swaps [Member] | Other (Income) Expense, Net [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	(4)	$ 2
Interest Rate Swaps [Member] | Interest Expense, Net [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	$ (2)	$ (1)

XML

Financial Instruments and Fair Value Measurements, Assets Measured at Fair Value on Non-Recurring Basis (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 29, 2018	Sep. 29, 2018
Impairment [Abstract]
Indefinite-lived trademarks	$ 0	$ 0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	7	0
Impairment charges	7	0
Fair Value Adjustment [Abstract]
Fair value of long-term indebtedness in excess of book value	45
Fair Value on Nonrecurring Basis [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248
Goodwill	2,941	2,944
Definite lived intangible assets	1,054	1,092
Property, plant, and equipment	2,457	2,488
Total	6,700	6,772
Fair Value on Nonrecurring Basis [Member] | Level 1 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	0	0
Total	0	0
Fair Value on Nonrecurring Basis [Member] | Level 2 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	0	0
Total	0	0
Fair Value on Nonrecurring Basis [Member] | Level 3 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248
Goodwill	2,941	2,944
Definite lived intangible assets	1,054	1,092
Property, plant, and equipment	2,457	2,488
Total	$ 6,700	$ 6,772

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Income Taxes [Abstract]
Transition tax benefit		$ (95)
Effective tax rate	21.00%
Share-based compensation excess tax benefit	(2.00%)
Research and development credits	(1.00%)
U.S. state income taxes	4.00%

XML

Operating Segments, Selected Information by Reportable Segment (Details) $ in Millions	3 Months Ended
	Dec. 29, 2018 USD ($) Segment	Dec. 30, 2017 USD ($)	Sep. 29, 2018 USD ($)
Selected Information by Reportable Segment [Abstract]
Number of reportable segments | Segment	3
Net sales	$ 1,972	$ 1,776
Operating income	176	163
Depreciation and amortization	138	129
Total assets	8,972		$ 9,131
Total goodwill	2,941		2,944
Operating Segment [Member] | Engineered Materials [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	669	648
Operating income	94	88
Depreciation and amortization	31	29
Total assets	1,964		1,998
Total goodwill	630		633
Operating Segment [Member] | Health, Hygiene & Specialties [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	702	577
Operating income	49	37
Depreciation and amortization	54	46
Total assets	3,811		3,913
Total goodwill	903		902
Operating Segment [Member] | Consumer Packaging [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	601	551
Operating income	33	38
Depreciation and amortization	53	$ 54
Total assets	3,197		3,220
Total goodwill	$ 1,408		$ 1,409

XML

Operating Segments, Selected Information by Geography (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017	Sep. 29, 2018
Selected Information by Geography [Abstract]
Net sales	$ 1,972	$ 1,776
Long-lived assets	6,766		$ 6,846
Reportable Geography [Member] | North America [Member]
Selected Information by Geography [Abstract]
Net sales	1,605	1,466
Long-lived assets	5,685		5,764
Reportable Geography [Member] | South America [Member]
Selected Information by Geography [Abstract]
Net sales	96	74
Long-lived assets	332		320
Reportable Geography [Member] | Europe [Member]
Selected Information by Geography [Abstract]
Net sales	204	170
Long-lived assets	451		463
Reportable Geography [Member] | Asia [Member]
Selected Information by Geography [Abstract]
Net sales	67	$ 66
Long-lived assets	$ 298		$ 299

XML

Operating Segments, Selected Information by Product Line (Details) - Net Sales [Member]	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Engineered Materials [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%
Engineered Materials [Member] | Performance Materials [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	39.00%	43.00%
Engineered Materials [Member] | Engineered Products [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	61.00%	57.00%
Health, Hygiene & Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%
Health, Hygiene & Specialties [Member] | Health [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	18.00%	19.00%
Health, Hygiene & Specialties [Member] | Hygiene [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	52.00%	44.00%
Health, Hygiene & Specialties [Member] | Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	30.00%	37.00%
Consumer Packaging [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%
Consumer Packaging [Member] | Rigid Open Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	44.00%	43.00%
Consumer Packaging [Member] | Rigid Closed Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	56.00%	57.00%

XML

Share Repurchase Program (Details) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Dec. 29, 2018	Sep. 29, 2018
Share Repurchase Program [Abstract]
Authorized amount of share repurchase program		$ 500
Number of shares repurchased and retired (in shares)	1,132
Shares repurchased and retired	$ 54
Remaining amount of share repurchase program	$ 412

XML

Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Basic and Diluted Net Income Per Share [Abstract]
Antidilutive shares excluded from computation of earnings per share (in shares)	3.0
Numerator [Abstract]
Consolidated net income	$ 88	$ 163
Denominator [Abstract]
Weighted average common shares outstanding - basic (in shares)	131.1	131.0
Dilutive shares (in shares)	2.7	5.0
Weighted average common and common equivalent shares outstanding - diluted (in shares)	133.8	136.0
Per Common Share Income [Abstract]
Basic (in dollars per share)	$ 0.67	$ 1.24
Diluted (in dollars per share)	$ 0.66	$ 1.20

XML

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Accumulated Other Comprehensive Loss [Roll Forward]
Other comprehensive income (loss) before reclassifications	$ (26)	$ (11)
Net amount reclassified from accumulated other comprehensive income (loss)	(2)	3
Provision for income taxes	7	(4)
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(156)	(68)
Ending balance	(177)	(80)
Currency Translation [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(175)	(48)
Other comprehensive income (loss) before reclassifications	(4)	(24)
Net amount reclassified from accumulated other comprehensive income (loss)	0	0
Provision for income taxes	0	0
Ending balance	(179)	(72)
Defined Benefit Pension and Retiree Health Benefit Plans [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(13)	(16)
Other comprehensive income (loss) before reclassifications	0	(1)
Net amount reclassified from accumulated other comprehensive income (loss)	0	0
Provision for income taxes	0	0
Ending balance	(13)	(17)
Interest Rate Swaps [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	32	(4)
Other comprehensive income (loss) before reclassifications	(22)	14
Net amount reclassified from accumulated other comprehensive income (loss)	(2)	3
Provision for income taxes	7	(4)
Ending balance	$ 15	$ 9

XML

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Statements of Income (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Guarantor and Non-Guarantor Financial Information [Abstract]
Percentage ownership in guarantor subsidiaries	100.00%
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	$ 1,972	$ 1,776
Cost of goods sold	1,619	1,447
Selling, general and administrative	124	117
Amortization of intangibles	42	38
Restructuring and impairment charges	11	11
Operating income	176	163
Other expense (income), net	0	9
Interest expense, net	64	62
Equity in net income of subsidiaries	0	0
Income before income taxes	112	92
Income tax expense	24	(71)
Net income	88	163
Comprehensive net income	67	151
Eliminations [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	0	0
Cost of goods sold	0	0
Selling, general and administrative	0	0
Amortization of intangibles	0	0
Restructuring and impairment charges	0	0
Operating income	0	0
Other expense (income), net	0	0
Interest expense, net	0	0
Equity in net income of subsidiaries	179	164
Income before income taxes	(179)	(164)
Income tax expense	(24)	71
Net income	(155)	(235)
Comprehensive net income	(155)	(235)
Parent [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	0	0
Cost of goods sold	0	0
Selling, general and administrative	0	0
Amortization of intangibles	0	0
Restructuring and impairment charges	0	0
Operating income	0	0
Other expense (income), net	0	0
Interest expense, net	0	0
Equity in net income of subsidiaries	(112)	(92)
Income before income taxes	112	92
Income tax expense	24	(71)
Net income	88	163
Comprehensive net income	88	163
Issuer [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	141	138
Cost of goods sold	85	106
Selling, general and administrative	13	12
Amortization of intangibles	0	0
Restructuring and impairment charges	0	0
Operating income	43	20
Other expense (income), net	1	5
Interest expense, net	5	5
Equity in net income of subsidiaries	(67)	(72)
Income before income taxes	104	82
Income tax expense	16	(81)
Net income	88	163
Comprehensive net income	79	160
Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	1,377	1,225
Cost of goods sold	1,142	989
Selling, general and administrative	87	80
Amortization of intangibles	36	31
Restructuring and impairment charges	7	7
Operating income	105	118
Other expense (income), net	1	7
Interest expense, net	45	43
Equity in net income of subsidiaries	0	0
Income before income taxes	59	68
Income tax expense	0	0
Net income	59	68
Comprehensive net income	59	68
Non-Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	454	413
Cost of goods sold	392	352
Selling, general and administrative	24	25
Amortization of intangibles	6	7
Restructuring and impairment charges	4	4
Operating income	28	25
Other expense (income), net	(2)	(3)
Interest expense, net	14	14
Equity in net income of subsidiaries	0	0
Income before income taxes	16	14
Income tax expense	8	10
Net income	8	4
Comprehensive net income	$ (4)	$ (5)

XML

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Balance Sheet (Details) - USD ($) $ in Millions	Dec. 29, 2018	Sep. 29, 2018	Dec. 30, 2017	Sep. 30, 2017
Assets [Abstract]
Current assets	$ 2,206	$ 2,285
Intercompany receivable	0	0
Property, plant and equipment, net	2,457	2,488
Other assets	4,309	4,358
Total assets	8,972	9,131
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	1,179	1,237
Intercompany payable	0	0
Other long-term liabilities	6,338	6,460
Stockholders' equity	1,455	1,434	$ 1,174	$ 1,015
Total liabilities and stockholders' equity	8,972	9,131
Eliminations [Member]
Assets [Abstract]
Current assets	0	0
Intercompany receivable	(2,154)	(2,252)
Property, plant and equipment, net	0	0
Other assets	(8,904)	(8,769)
Total assets	(11,058)	(11,021)
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	0	0
Intercompany payable	(2,154)	(2,252)
Other long-term liabilities	0	0
Stockholders' equity	(8,904)	(8,769)
Total liabilities and stockholders' equity	(11,058)	(11,021)
Parent [Member]
Assets [Abstract]
Current assets	0	0
Intercompany receivable	248	296
Property, plant and equipment, net	0	0
Other assets	1,593	1,544
Total assets	1,841	1,840
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	18	18
Intercompany payable	0	0
Other long-term liabilities	368	388
Stockholders' equity	1,455	1,434
Total liabilities and stockholders' equity	1,841	1,840
Issuer [Member]
Assets [Abstract]
Current assets	214	249
Intercompany receivable	1,878	1,907
Property, plant and equipment, net	79	79
Other assets	6,326	6,247
Total assets	8,497	8,482
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	248	218
Intercompany payable	0	0
Other long-term liabilities	5,851	5,945
Stockholders' equity	2,398	2,319
Total liabilities and stockholders' equity	8,497	8,482
Guarantor Subsidiaries [Member]
Assets [Abstract]
Current assets	1,243	1,240
Intercompany receivable	0	0
Property, plant and equipment, net	1,660	1,684
Other assets	4,808	4,849
Total assets	7,711	7,773
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	621	635
Intercompany payable	2,154	2,252
Other long-term liabilities	58	68
Stockholders' equity	4,878	4,818
Total liabilities and stockholders' equity	7,711	7,773
Non-Guarantor Subsidiaries [Member]
Assets [Abstract]
Current assets	749	796
Intercompany receivable	28	49
Property, plant and equipment, net	718	725
Other assets	486	487
Total assets	1,981	2,057
Liabilities and Stockholders' Equity [Abstract]
Current liabilities	292	366
Intercompany payable	0	0
Other long-term liabilities	61	59
Stockholders' equity	1,628	1,632
Total liabilities and stockholders' equity	$ 1,981	$ 2,057

XML

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Statements of Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 29, 2018	Dec. 30, 2017
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	$ 161	$ 153
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(75)	(94)
Proceeds from sale of assets	0	3
(Contributions) distributions to/from subsidiaries	0	0
Intercompany advances (repayments)	0	0
Other investing activities, net		0
Net cash from investing activities	(75)	(91)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	(110)	(108)
Proceeds from issuance of common stock	5	4
Repurchase of common stock	(52)	0
Payment of tax receivable agreement	(16)	(37)
Changes in intercompany balances	0	0
Net cash from financing activities	(173)	(141)
Effect of exchange rate changes on cash	(1)	1
Net change in cash	(88)	(78)
Cash and cash equivalents at beginning of period	381	306
Cash and cash equivalents at end of period	293	228
Eliminations [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	0	0
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	0
Proceeds from sale of assets	0	0
(Contributions) distributions to/from subsidiaries	0	0
Intercompany advances (repayments)	(38)	(69)
Other investing activities, net		0
Net cash from investing activities	(38)	(69)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	0	0
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0
Changes in intercompany balances	38	69
Net cash from financing activities	38	69
Effect of exchange rate changes on cash	0	0
Net change in cash	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Parent [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	0	0
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	0
Proceeds from sale of assets	0	0
(Contributions) distributions to/from subsidiaries	47	(4)
Intercompany advances (repayments)	0	0
Other investing activities, net		0
Net cash from investing activities	47	(4)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	0	0
Proceeds from issuance of common stock	5	4
Repurchase of common stock	(52)
Payment of tax receivable agreement	(16)	(37)
Changes in intercompany balances	16	37
Net cash from financing activities	(47)	4
Effect of exchange rate changes on cash	0	0
Net change in cash	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Issuer [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	55	35
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	(3)
Proceeds from sale of assets	0	0
(Contributions) distributions to/from subsidiaries	(47)	4
Intercompany advances (repayments)	38	69
Other investing activities, net		0
Net cash from investing activities	(9)	70
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	(108)	(106)
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0
Changes in intercompany balances	0	0
Net cash from financing activities	(108)	(106)
Effect of exchange rate changes on cash	0	0
Net change in cash	(62)	(1)
Cash and cash equivalents at beginning of period	133	18
Cash and cash equivalents at end of period	71	17
Guarantor Subsidiaries [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	155	139
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(59)	(61)
Proceeds from sale of assets	0	0
(Contributions) distributions to/from subsidiaries	0	0
Intercompany advances (repayments)	0	0
Other investing activities, net		0
Net cash from investing activities	(59)	(61)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	(2)	(2)
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0
Changes in intercompany balances	(93)	(86)
Net cash from financing activities	(95)	(88)
Effect of exchange rate changes on cash	0	0
Net change in cash	1	(10)
Cash and cash equivalents at beginning of period	4	12
Cash and cash equivalents at end of period	5	2
Non-Guarantor Subsidiaries [Member]
Consolidating Statement of Cash Flows [Abstract]
Cash flow from operating activities	(49)	(21)
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(16)	(30)
Proceeds from sale of assets	0	3
(Contributions) distributions to/from subsidiaries	0	0
Intercompany advances (repayments)	0	0
Other investing activities, net		0
Net cash from investing activities	(16)	(27)
Cash Flow from Financing Activities [Abstract]
Repayments on long-term borrowings	0	0
Proceeds from issuance of common stock	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0
Changes in intercompany balances	39	(20)
Net cash from financing activities	39	(20)
Effect of exchange rate changes on cash	(1)	1
Net change in cash	(27)	(67)
Cash and cash equivalents at beginning of period	244	276
Cash and cash equivalents at end of period	$ 217	$ 209